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ABSTRACT 
 
Objective: Hyperprolactinemia and related adverse effects often occur with 
antipsychotics, especially Risperidone. We investigated the effect of 
adjunctive treatment with Aripiprazole on hyperprolactinemia in patients 
with schizophrenia maintained on Risperidone. 
 
Method: Thirty patients who were on stable doses of Risperidone were 
randomized either to get 10 mg of Aripiprazole or placebo in a double bind 
fashion. Serum prolactin levels were measured at the baseline and at the end 
of 8 weeks. Symptoms and side effects were assessed with the Brief 
Psychiatric Rating Scale (BPRS), Scale for the Assessment for positive 
symptoms, Scale for Assessment of Negative symptoms, Simpson- Angus 
Rating scale, Barnes Akathisia Rating Scale, Arizona Sexual Experience 
Scale and Prolactin Related Adverse Event Questionnaire at baseline, weeks 
2, 4, 6 and 8. 
 
Results: Prolactin levels of patients receiving Aripiprazole significantly 
decreased compared to the placebo group, at the end of 8 weeks. In the 
Aripiprazole group, patients had 60.64% reduction in prolactin level at week 
8 whereas no reduction was observed in placebo. Statistically significant 
reduction in scores of Arizona Sexual Experience Scale and Prolactin 
Related Adverse Event Questionnaire were noted in Aripiprazole group 
which denote improvement in sexual side effects. No differences were 
observed on BPRS, Scale for the Assessment of Positive symptoms, Scale 
for Assessment of Negative Symptoms, Simpson-Angus Rating Scale, and 
Barnes Akathisia Rating scale scores were noted. 
 
Conclusions: Adjunctive Aripiprazole treatment improved 
hyperprolactinemia in both gender, resulting in clinical improvement, with 
no significant effects on psychopathology and extra pyramidal symptoms. 
Partial agonistic property of Aripiprazole could be the cause of this 
observation. 
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SUPLEMENTATION OF ARIPIPRAZOLE IN RISPERIDONE 
INDUCED HYPERPROLACTINEMIA: A DOUBLE BLIND 
RANDOMIZED PLACEBO CONTROLLED TRIAL 
SCHIZOPHRENIA 
Schizophrenia is the disorder of CNS characterized by positive 
symptoms, negative symptoms and cognitive symptoms. Positive symptoms 
include delusions, hallucinations and thought disorganization, negative 
symptoms includes loss of motivation and emotional vibrancy. (1) WHO 
report says “Schizophrenia is a severe form of mental illness affecting about 
7 per thousand of the adult population, mostly in the age group 15-35 years. 
Schizophrenia affects about 24 million people word wide. (2). 
         It was postulated that abnormal dopaminergic activity and 
glutaminergic activity in the brain leads to pathogenesis of schizophrenia. 
Positive symptoms are due to increased dopamine activity in the meso limbic 
circuits. Negative symptoms are due to decrease in dopamine activity in the 
pre-frontal cortical neurons. Cognitive disturbances are mainly due to 
disturbances in Glutamate activity. (1) 
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Fig 1 shows key dopamine pathways in the brain. 
 
 
 
Fig - 1
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ANTIPSYCHOTICS 
Antipsychotic medications are the mainstay of treatment in 
schizophrenia. By blocking dopamine in certain regions of the brain they 
bring improvement in psychosis, but the same action in other parts of the 
regions results in unnecessary adverse reactions. (3) 
    Anti psychotic drugs causes reduction in dopamine activity in the 
Meso-limbic system which causes improvement in positive symptoms. 
(Fig2) 
 
Fig - 2 
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Antipsychotics by blocking dopamine activity in Meso cortical pathway may 
add on to the cognitive as well as negative symptoms. (Fig 3) 
 
 
Fig - 3 
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The dopamine blockade action of antipsychotics in Nigro striatal dopamine 
pathway   causes extra pyramidal side effects. (Fig 4) 
 
Fig - 4 
Anti psychotics block dopamine in Tuberoinfundibular pathway which 
causes increase in serum prolactin level. (Fig 5)                                           
 
Fig - 5 
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ANTIPSYCHOTICS- CLASSIFICATION 
Antipsychotics are classified into conventional or first generation 
antipsychotics and newer second generation antipsychotics. After the 
introduction of second generation antipsychotic there are so many studies 
published that showed these agents are superior to conventional 
antipsychotics in terms of efficacy especially negative symptoms and 
adverse effects. At the same time there are various studies that showed that 
there was no difference between first generation antipsychotics and second 
generation antipsychotics except Clozapine.(4) (5) Meta analysis done with 
the 148 trials with sample size of 18,272 patients showed that second 
generation antipsychotics are not a homogenous group. Agents like 
Olanzapine, Risperidone, Clozapine and Amisulpride are significantly better 
than conventional antipsychotic agents. (6) 
       However because of favorable side effect profile especially extra 
pyramidal side effects, second generation antipsychotics are commonly used 
first line agents clinically. (7) 
          Risperidone was the first second generation antipsychotic medication 
to be approved following clozapine. Risperidone is an atypical antipsychotic, 
widely available, relatively inexpensive and extensively used in India. Its 
efficacy has been well established in literature. CATIE trial says it is 
comparable with other second generation antipsychotics except clozapine 
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and first generation antipsychotic agents. (5)  A Canadian multicenter study 
says that Risperidone has good efficacy in both positive and negative 
symptoms and superior over placebo. (8) It is widely used over the other 
second generation anti psychotics like Olanzapine because of lesser side 
effect profile in terms of weight gain, glycemic control and lipid profile. (9)  
Randomized control trial showed that risperidone was superior to olanzapine 
in terms of metabolic side effects and slightly better for positive and mood 
symptoms. (10) 
       However, Risperidone has its own unique side effect profile. Raised 
prolactin levels and its secondary complications may force the clinician to 
reduce the dose or change the medication. (11)  
     Antipsychotic drugs induced hyperprolactinemia and related morbidity 
is a neglected area in clinical practice as well as in research. 
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HYPERPROLACTINEMIA 
Prolactin is a single chain polypeptide hormone consisting of 199 AA 
(23 k Da) stabilized by 3 sulphide bonds. Apart from lactation it is recently 
implicated in more than 300 physiological functions mainly related to 
reproduction and homeostasis. (12) It is secreted from the anterior pituitary 
gland. Prolactin receptors are found in almost all tissues and organs of the 
body. (13) Mechanisms that control the synthesis of prolactin are complex. It 
includes endogenous regulatory agents, feedback loops and circadian 
rhythm. It is also under tonic inhibition by the hypothalamus. This is 
mediated by number of factors of which Dopamine is very important. 
Dopamine is released by neuroendocrine cell of the tuberoinfundibular tract, 
reaches the lactotrophs through the portal system. Dopamine binds to D2 
receptors on lactotrophs, receptor activation leads to inhibition of prolactin 
secretion. Disinhibition of lactotrophs by Dopamine antagonists 
(neuroleptics) results in increase in prolactin release. Persistent Disinhibition 
leads to elevated plasma concentration or hyperprolactinemia. (14) 
     Hyper prolactinemia suppresses gonadotropin-releasing hormone 
(GnRH), which in turn results in lesser gonadotropin release. This impairs 
gonadal steroidogenesis in both men and women. Hyper prolactinemia is 
associated with inhibited reproductive function and symptoms such as 
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galactorrhea, amenorrhea, gynaecomastia, erectile dysfunction, and 
anorgasmia. (15) (16) (17) 
Antipsychotics induced hyperprolactinemia causes spontaneous 
galactorrhea of varying severity. It occurs more in women of premenopausal 
age group, who had children. It is very distressing side effect encountered by 
women. It is rare in male patients. 
     Amenorrhea occurs in about 30% of pre-menopausal women as a 
consequence of hyperprolactinemia due to risperidone. It may lead to 
potential negative consequences like increased risk of osteoporosis or 
neoplasia, discontinuation of treatment and worsening of psychopathology. 
      Patients with long term hyperprolactinemia have reduction in bone 
mineral density and osteoporosis. This is due to decrease in estrogen and 
testosterone secretion. In a study done with 45 patients with chronic 
antipsychotic use and high prolactin levels, there is decrease in bone mineral 
density measured from dual energy X-ray absorptiometry. This decrease in 
bone mineral density is secondary to hypogonadism due to increase in 
prolactin level. (18) 
      Approximately one-third of breast cancers are prolactin dependent, we 
don’t know the influence of risperidone induced hyperprolactinemia on 
cancer prone patients. There are studies stating association of 
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hyperprolactinemia and breast cancer but it needs further prospective studies 
to establish causal relationship. (19)   
Patients often underreport sexual dysfunction and majority of them 
discontinue treatment because of this sexual side effects. (20) One of the 
primary reasons of sexual dysfunctions is Antipsychotic induced 
hyperprolactinemia. 
      Among the antipsychotics Risperidone is associated with greatest 
increase in prolactin level, more than typical agents like Haloperidol. (21) 
Approximately 90% of the patients treated with Risperidone have raised 
prolactin level above base level. (15) (22) Possible explanation could be low 
penetration of Blood Brain Barrier (BBB) by Risperidone where pituitary 
gland lies outside BBB. (23)  Side effects related to increased prolactin level 
are seen in 45% of the patients. (15) 
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Hyperprolactinemia- Management 
Generally, three strategies have been recommended for the treatment 
of Risperidone induced hyperprolactinemia. Reduction of the antipsychotic 
dose, administration of adjunctive dopamine agonists, such as amantadine or 
bromocriptine and discontinuation of current treatment with switch to a 
different antipsychotic agent. These strategies, however can lead to other 
adverse consequences, such as worsening of psychotic symptoms, which 
may put the patient at a greater risk for adverse consequences, possibly 
worse than experiencing hyper prolactinemia itself. Relapse of psychosis 
can  lead to adverse psychosocial consequences like losing skills to care, 
work and socialize, suicide, losing the job, marital disharmony, financial 
burden, hospitalization, care givers burden, etc. Switching to prolactin -
sparing second generation such as Olanzapine, Quetiapine can be an 
effective treatment of hyper prolactinemia. However switching to these 
agents is not always possible in clinical practice especially if patient has 
already responded well and clinician/patient is unwilling to take risk on the 
clinical stability. Moreover medications like Olanzapine will produce other 
adverse effects like weight gain, excessive sedation, diabetes and cardiac 
abnormality. (24) 
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ARIPIPRAZOLE              
  Aripiprazole, a dopamine partial agonist, offers a novel, effective and 
well-tolerated treatment approach for patients with schizophrenia. Dopamine 
partial agonists are a new class of antipsychotic drugs. They have a lower 
intrinsic activity at receptors than full agonists, allowing them to act either as 
a functional agonist or a functional antagonist, depending on the surrounding 
levels of naturally occurring dopamine (neurotransmitter).  
      In the absence of a full agonist, partial agonists show functional 
agonist activity, binding to the receptor to produce a response. In the 
presence of a full agonist, partial agonists show functional antagonist 
activity.  
      Hence it should act as a functional antagonist in the mesolimbic 
dopamine pathway, where it blocks excessive dopamine activity and 
improves positive symptoms. It acts as functional agonist in the mesocortical 
pathway, where it improves reduced dopamine activity and thereby 
improving negative symptoms and cognitive impairment. 
       Aripiprazole should avoid the complete blockade of the nigrostriatal 
or tuberoinfundibular pathways, associated with extra pyramidal symptoms 
(EPS) and elevated prolactin levels, respectively. (25) Theoretically it should 
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increase dopamine concentration in tuberoinfundibular system, thereby it 
should improve hyperprolactinemia.   
      Aripiprazole has a good tolerability profile: no extra pyramidal 
symptoms, least sedating, minimal weight gain, minimal effects on lipids 
and glucose. (24) (26) (27) Aripiprazole has favorable effect on 
prolactinemia. 
      There are literatures which states, Aripiprazole reduces serum 
prolactin level due to its partial agonistic action as it increases Dopamine 
level in tuberoinfundibular system.  
      Adding Aripiprazole to an ongoing antipsychotic regime, just to treat 
hyperprolactinemia is an interesting area of research. 
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REVIEW OF LITERATURE 
There are studies showing decrease in serum prolactin level even to 
normalization when Aripiprazole is used. (28) (29) 
  Vieta et al, sample size 347 compared   Aripiprazole with haloperidol 
and found that there is no significant rise above baseline prolactin level in 
Aripiprazole group. (30)  
       In another randomized comparative trial, 83 patients with psychosis, 
where Aripiprazole was compared with risperidone, 93% in risperidone 
group had increased prolactin level whereas only 5% in Aripiprazole group.. 
(31)  
      Open label trial of changing to Aripiprazole for seven patients with 
symptomatic hyperprolactinemia due to atypical antipsychotic like 
risperidone, Amisulpride causes reduction in serum prolactin level up to 
93.8%. (32)  
       In this RCT, (33) with 414 subjects, authors compared Aripiprazole 15 
mg, 30 mg, with 10 mg Haloperidol or placebo. It was found there was mean 
reduction of 54.8% in Aripiprazole group whereas there is significant 
increase by 143% in haloperidol group. 
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In this study (34) with sample size of 262 patients with acute mania, 
authors compared Aripiprazole with placebo for efficacy and adverse effects. 
It is found that prolactin levels were reduced by 47.4% in 3 weeks.   
        Steven G et al,  (35) with sample size 404 compared Aripiprazole 20 
mg ( n= 101), 30 mg ( n= 101) with Risperidone 6 mg (n= 99) and placebo 
(n=103) in terms of efficacy and adverse effects and found that both the 
Aripiprazole group had a numerical decrease in serum prolactin level 
compared to the base line. 
      Meta analysis with 17 studies, of sample size 3,489 were given 
aripiprazole monotherapy, as an adjuvant to existing regime showed. 
aripiprazole lowered prolactin levelson  an average of 74.3% across all 
studies. This effect is also seen even in psychotic patients with prolactinoma. 
Aripiprazole lowered prolactin levels by 59.3% in subjects with even normal 
baseline levels.  Authors Concluded that aripiprazole may play an important 
role in treating psychiatric  patients with hyper prolactinemia.. (36) 
        Marder et al, in a meta-analysis (37) with total sample size of 1,549, 
compared patients receiving 2 mg- 30 mg Aripiprazole (N = 932) , with 
patients receiving Haloperidol 5 to 20 mg (N = 201) and placebo and found 
that patients on Aripiprazole arm had mean reduction of serum prolactin 
level from the base line by 56.5 %( p < 0.001). 
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EVIDENCE FOR ARIPIPRAZOLE AS ADJUNCTIVE 
AGENT FOR TREATING HYPERPROLACTINEMIA 
 It was reported that in a patient with bipolar disorder maintaining on 
150 mg of Haloperidol deconoate , with symptomatic hyperprolactinemia 
when treated with adjunctive Aripiprazole up to 30 mg had reduction in 
prolactin level by 94% in spite of continuing Haloperidol. (38) 
       In a study (24), authors concluded that addition of Aripiprazole 
normalizes hyperprolactinemia in patients who were stabilized on 
haloperidol. Fifty-six patients with hyperprolactinemia taking haloperidol 
were enrolled. Haloperidol dose was fixed. Aripiprazole was dosed at 15 
mg/day for the first 4 weeks, then 30 mg/day for the following 4 weeks. 
Prolactin levels of patients receiving Aripiprazole significantly decreased 
over time. In the Aripiprazole group, 88.5% of patients at week 8 had 
prolactin levels normalize compared to 3.6% of patients receiving placebo. 
Among 11 female patients with menstrual disturbances randomly assigned to 
Aripiprazole, seven patients regained menstruation during the study, whereas 
none receiving placebo did.  
     There is an open label prospective study with 19 patients where 
authors studied adjunctive treatment of Aripiprazole in patients maintaining 
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with risperidone causing reduction in serum prolactin level at the end of 8 
weeks. (39)  
There are case reports suggesting similar changes when Aripiprazole 
was added to Risperidone, (40) 
       It was reported that in 17 year old patient with Schizophrenia on 
Risperidone 4 mg and Depot Risperidone 25 mg bi weekly, with 
symptomatic hyperprolactinemia when treated with adjuvant Aripiprazole 15 
mg, there was reduction of prolactin level from the baseline by 84.9%. (41)  
        But so far there is no randomized controlled study with Risperidone. 
As Risperidone has become one of the common atypical antipsychotics in 
treating schizophrenia, we need more research about managing Risperidone 
induced hyperprolactinemia. 
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AIMS 
 
Aim of our research is to study: 
 
1. Whether augmentation of Aripiprazole reduces serum prolactin levels 
and symptoms related to it in patients who are stable on Risperidone. 
2. Our secondary outcome measures are to evaluate whether adjunctive 
Aripiprazole causes improvement in positive and negative symptoms 
of schizophrenia. 
3. To study any emergent side effects to this augmentation. 
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INCLUSION CRIETERIA 
 
1. Patients in the age group of 15- 45, with the diagnosis of   
Schizophrenia according to Diagnostic and Statistical Manual IV TR. 
2. Patient should be maintaining on the stable dose of Risperidone for at   
least 12 weeks. 
3. Patients who are able to give written informed consent.  
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EXCLUSION CRIETERIA 
 
1. Patients on other oral/ DEPOT antipsychotics.  
2. Patients having exacerbation of psychotic symptoms where dose 
Modification or change of antipsychotic agents is required. 
3. Patients having adverse effect to current treatment regime which   
Requires dose modification.  
4. Patients who have seizure disorder or other serious medical problems. 
5. Patients who are pregnant or lactating.  
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TOOLS 
1. A Structured Proforma to collect socio-demographic and clinical 
variables 
2. Brief Psychiatric Rating Scale. (BPRS)  
3. Scale for Assessment of Positive Symptoms. (SAPS) 
4. Scale for Assessment of Negative Symptoms. ( SANS) 
5. Simpson-Angus Rating Scale for Extra pyramidal Side Effects. 
6. Barnes- Akathisia Rating Scale.  
7. Arizona sexual experience scale. 
8. Prolactin Related Adverse Event Questionnaire. 
9. Serum Prolactin assay in mIU/ ml by Sandwich principle. 
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BPRS 
The BPRS (Overall and Gorham, 1962) is one the most widely used 
instruments for assessing clinical change in psychiatric patients. It has 18 
items, a seven-category dimension of severity, ranging from 0 (not present) 
to 6 (extremely severe). The available evidence suggests that the BPRS is 
both valid and reliable in assessing the psychopathology. The median inter - 
rater reliability scores across the 18 items of the scale are reported to range 
between .63 and .88.  (42) (43) 
Scale for the Assessment of Positive Symptoms (SAPS) and 
Scale for assessment of negative symptoms 
SAPS and SANS were designed to provide detailed assessment of 
positive and negative symptoms of schizophrenia. Domains in SAPS include 
hallucinations, delusions, bizarre behavior and thought disorder. SANS 
include affective flattening, poverty of speech, apathy, anhedonia and 
inattentiveness. Each instrument contains 30 fully anchored items. Each item 
has rating from 0 to 5. The total scores ranges from 0 to 150 for each 
instrument. Good to excellent interrater reliability has been demonstrated for 
each instrument. Each scale has high internal consistency. Validity is 
supported by correlation with other symptom severity instruments. These 
scales provide comprehensive characterization of symptomatology. (44) 
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Barnes Akathisia Rating Scale 
This is the rating scale for drug-induced akathisia. It contains 
diagnostic criteria for pseudoakathisia, and mild, moderate, and severe 
akathisia. It includes items for rating the observable, restless movements 
which characterize the condition, the subjective awareness of restlessness, 
and any distress associated with the akathisia. There is also an item for rating 
global severity. The inter-rater reliability for the scale items (Cohen's x) 
ranged from 0.738 to 0.955. (45) 
Simpson Angus Rating Scale for Extra pyramidal side Effects 
It was developed to monitor the side effects of antipsychotic agents. It 
contains ten items. Each item is rated on a five point severity scale ranging 
from 0-4. Scores are reported as mean on all the 10 items with .3, as upper 
limits of normal. It focus on parkinsonian symptoms especially rigidity. It 
has good reliability and validity. This scale is used widely in clinical and 
research settings. (46) 
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Arizona Sexual Experience Scale (ASEX) 
The Arizona Sexual Experiences Scale (ASEX) is a five-item rating 
scale that quantifies sex drive, arousal, vaginal lubrication/penile erection, 
ability to reach orgasm, and satisfaction from orgasm. Total scores range 
from 5 to 30, with the higher the score, more severe the sexual dysfunction. 
It has high positive and negative predictive value. ASEX has excellent 
internal consistency and scale reliability (alpha = .9055). The ASEX also has 
strong test–retest reliability. It is more valid and sensitive tool to measure 
sexual dysfunction. Other advantages include the questions are short, easy to 
understand, easy to score and interpret.  (47) 
Prolactin Related Adverse Event Questionnaire 
It is a scale developed to objectively measure adverse events related to 
hyperprolactinemia. It has three main items, menstrual disturbances, chest 
symptoms and penile functions. There are 3 sub items in menstrual 
irregularity, 5 sub items in chest symptoms and 4 sub items in penile 
function. Each sub items have severity ranges from 0-5, with higher the 
score more the severity. 
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Prolactin Measurement 
It is measured by ECLIA- Electrochemiluminescence Immuno assay. 
This is based on the principle called quantitative sandwich immunoassay. 
The minimal detectable concentration of human Prolactin by this assay is 
estimated to be 1.5 ng/mL. This kit exhibits no detectable cross-reaction with 
human FSH, LH, and TSH, hCG and hGH. This immunoassay is calibrated 
against WHO, 3rd IS, 84/500. In this assay, no hook effect is observed up to 
10,000 ng/mL The monoclonal antibodies used are highly specific against 
prolactin.  
Patients are asked to give early morning fasting sample and also asked 
to be abstinent from sexual intercourse or any kind of stimulation of breast 
on the previous night.  
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SAMPLE SIZE CALCULATION 
 
Shim et al, 2007 (24), found that haloperidol (20 to 25mg) causing a 
mean increase of prolactin level by 94.5 (SD 38.1) ng/ml. Earlier studies 
have found that risperidone 6mg causing similar increase in the prolactin 
level. Extrapolating these estimates, in this study, we hypothesize that there 
would be  > 50% fall in the prolactin levels in Aripiprazole group than 
placebo group. To detect this, keeping alpha at 0.05, power of the study 80 
and expected drop out rate at 30%, we needed 15 patients in each 
Aripiprazole and placebo groups.  
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METHODOLOGY 
We screened all the patients who were attending our department since 
January 2010.  Patients who met the eligible criteria were included. We 
administered Structured Clinical Interview for DSM disorders and only 
patients who fulfill the Diagnostic and Statistical Manual of Mental 
Disorders IV TR criteria for schizophrenia were included in the study. We 
explained in detail about the project to the patients and his/her key family 
members accompanying the patient and obtained written informed consent 
from the patient. Totally 30 patients were recruited into the study.  
Randomization 
We did stratified block randomization so that we get equal male and 
female patients in the Aripiprazole and placebo groups. (Literature shows 
that incidence and effects of hyperprolactinemia differs between males and 
females). (24) 
Medications and Blinding 
PSG College of pharmacy prepared placebos looking similar to 
Aripiprazole (10 mg) tablets and packed them separately. Aripiprazole and 
placebo tablets were labeled as Drug A and Drug B for masking and the 
primary investigators and patients were blind to the medications thought out 
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the study. PSG College of pharmacy officially maintained the blinding till 
the completion of the study.  
       At the baseline we used Brief Psychiatric Rating Scale (BPRS), Scale 
for the assessment of positive symptoms (SAPS), and Scale for the 
assessment of negative symptoms (SANS) to assess the severity of 
psychopathology.  Simpson-Angus Rating Scale for Extra pyramidal Side 
Effects and Barnes akathisia scale to monitor extra pyramidal symptoms. 
       To assess the sexual dysfunctions we used Arizona sexual experience 
scale at the baseline and also we assessed menstrual irregularities and 
galactorrhea using Prolactin Related Adverse Event Questionnaire.  
       Prolactin level was done from the morning fasting blood at the baseline.  
        Patients were followed up for 8 weeks after baseline assessments. 
Each patient was given a sachet containing either Aripiprazole or placebo 
(both looking identical), 2 weeks at a time, and patients came once in 2 
weeks to collect the medications. At the end of every two weeks we repeated 
the BPRS, SAPS, SANS, AIMS, sexual dysfunctions questionnaire, 
Prolactin Related Adverse Event Questionnaire.   
  At the end of 8 weeks, we repeated BPRS, SAPS, SANS, AIMS, 
sexual dysfunctions questionnaire, Prolactin Related Adverse Event 
Questionnaire and did fasting prolactin level. 
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      Study was funded by ICMR and PSGIMSR. Study protocol was 
approved by institutional ethics committee of PSGIMSR. 
HYPERPROLACTINEMIA 
It is defined as the elevation of serum prolactin level above 324 IU/ ml 
in male patients or more than 496 IU/ ml in female patients. (Our lab 
reference) 
STATISTICAL ANALYSIS 
We compared the socio-demographic and clinical variables between 
Aripiprazole and placebo groups using student ‘t’ and chi-square tests. 
Student‘t’ test was used to assess the differences in the mean prolactin levels 
and chi-square test was used to assess the proportion of patients with 
hyperprolactinemia in both the groups. We  used repeat measures analysis of 
variance (ANOVA) to evaluate the effect of time and the time-by-group 
interaction for prolactin levels, BPRS score (clinical rating scale), SAPS 
score, SANS score and Simson- Angus rating score. We considered an alpha 
level of <0.05 as statistically significant. 
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RESULTS 
Fig: 6: Flowchart showing recruitment process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Drop outs: 2 
 
 
 
 
 
Total number of patients  
with Schizophrenia : 564 
Number of patients on 
Risperidone :  192 
Number of patients 
recruited in the study: 30 
Placebo  group 
(N=15) 
Male: 6 
Female: 9          
Aripiprazole group 
(N=15)   
Male: 9 
Female: 6 
 
End of the study  
(N = 13) 
Male: 5 
Female: 8 
 
End of the study 
(N=15) 
Male: 9 
Female: 6 
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We reviewed our medical records and found that, between 1st January 
2010 and 31st December 2010, 564 patients with the diagnosis of 
schizophrenia were attending our outpatient clinics. Among them 192 
patients were on Risperidone. We recruited consecutive 30 patients who met 
our intake criteria. (Fig 6)   
 
DROP OUTS   
                                  
Two patients from the placebo group dropped out and none from the 
aripiprazole group. First patient dropped out due to difficulties in attending 
follow up visits once in every 2 weeks. Second patient was dropped out from 
the study due to worsening of clinical picture. She developed insomnia, loss 
of appetite and worsening of behavioral problems. 
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Socio- demographic profile 
 
We had 9 males and 6 females in the Aripiprazole group and 6 males 
and 9 females in the placebo group and the mean age of the whole group was 
32.33 (SD=8.29) and there was no difference in the ages and gender between 
the groups. (Table 1) 
 
Table 1 - Mean age 
 
 Male 
n=15 
Female 
n=15 
Aripiprazole group 33.67 30.50 
Placebo group 31.17 30.67 
p= 0.92 
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Except one patient, all are literates and majority of them (50%) have 
educated between 6th class to 12th class. (Table: 2)  
 
Table: 2 Educational qualifications. 
 
Education. Frequency 
N 
Percentage 
Illiterate 1 3.3% 
Up to V std. 3 10% 
VI  std to XII std. 15 50% 
Diploma/ Under graduates 7 23.3% 
Post graduates/ Professional 
courses.  
4 13.3% 
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50% of them were married. (Table: 3) 
Table: 3- Marital status. 
 Married 
n= 15 (%) 
Unmarried 
n= 15(%) 
Aripiprazole group 10 (66.7) 5 (33.3) 
Placebo group 5 (33.3) 10 (66.7) 
p= 0.07 
 
There is no difference between the aripiprazole group and placebo 
group in marital status and educational status. 
The dose of Risperidone ranged between 4 mg to 10 mg. (Table: 4) 
Table: 4 – Risperidone dose. 
Variable. Mean Risperidone dose   
mg 
SD 
Total group 
 
6 1.174 
Aripiprazole group 6.27 1.49 
Placebo group 5.73 0.70 
p Value- 0.22 
SD- Standard deviation. 
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Prolactin level 
Baseline Serum Prolactin Level 
The mean prolactin level in the whole group was 1760.23 IU/L and 
there is no statistical difference between the Aripiprazole and placebo 
groups. The prolactin levels in females was consistently higher than males 
(p<0.001); however there is no statistical difference among the respective 
gender in the Aripiprazole and placebo groups. (Table: 5) 
Table: 5- Baseline Serum Prolactin Level 
 Total Mean Aripiprazole 
Mean (SD) 
Placebo 
Mean (SD) 
P value. 
Total 1760.23 1,408 (1336) 2,112 (1,648.3) 0.209 
Male 706.87 590. 56 (256.82)     881.33 
(297.77) 
0.07 
Female 2813.60 2,634.17 (1373.5) 2933.22 
(1674.67) 
0.723 
 
Prolactin level: 
At the end of 8 weeks, prolactin level in the Aripiprazole group had 
reduced significantly compared to placebo group, demonstrating a 
significant time effect, (f = 6.33, df= 1, 26, p = 0.018) and time by group 
interaction ( f = 5.512, df = 1, 26, p = 0.032) on repeated measures 
ANOVA. No significant effect was observed in the placebo group on time.  
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Table: 6 shows difference in prolactin level between the two study groups at 
the end of 8 weeks and it is statistically significant. 
Table: 6- Difference in Serum Prolactin level- At the end of 8 weeks. 
 Aripiprazole 
Mean (SD) 
Placebo 
Mean (SD) 
P value. 
End of 8 
weeks 
554.27 (558.9) 2,170 (1405.22) <0.001* 
*- t = _ 4.105, df (26), CI = 95%, (_2425.5 to _ 806.89)  
 
Univariate analysis (Student’s t test) also show that there is a 
significant reduction in prolactin level in the Aripiprazole group when 
compared to placebo group. (Table: 7). 
Table: 7-Mean Reduction in Prolactin level- Aripiprazole and placebo 
groups  
 Baseline 
Mean (SD) 
End of 8 
weeks 
Mean (SD) 
t- Value p- Value 
Aripiprazole  
Group 
1408 (1336) 554.27 
(558.9) 
3.727, df (14) 0.002* 
Placebo  
Group 
2,214.31 
(1.745.23) 
2170.46 
(1,405.22) 
- 0.877 
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Gender differences in prolactin level 
At the baseline, mean prolactin levels for females (2812.60) was much 
higher than males (707.87), which was statistically significant ( p value < 
0.001). However, as we had done gender based stratified randomization, 
mean prolactin levels in males were comparable between Aripiprazole and 
placebo groups and similarly mean prolactin levels in females were 
comparable between both the groups. Table: 8.  
Table: 8- Gender Differences in Prolactin level - Baseline 
Gender Aripiprazole 
Mean (SD)  
Placebo 
Mean (SD) 
p- Value. 
Male. 590. 56 
(256.82)      
881.33 
(297.77) 
0.07 
Female 2,634.17 
(1373.5) 
2933.22 
(1674.67) 
0.723 
 
At the end of 8 weeks, there is statistically significant difference in 
prolactin levels between Aripiprazole group and placebo group in both the 
gender. (Table: 9) 
Table: 9- Gender difference in Prolactin level- End of 8 weeks 
Gender Aripiprazole 
Mean (SD)  
Placebo 
Mean (SD) 
p- Value. 
Male. 218.33 
(131.99)      
1097.40 
(272.63) 
< 0.001* 
Female 1058.17 
(582.28) 
2841.12 
(1416.37) 
0.014* 
* - Statistically significant. 
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Hyperprolactinemia  
At the base line 86.7% of male patients and all the female patients 
have hyperprolactinemia.   At the end of 8 weeks, only 22.2% of male 
patients had hyperprolactinemia but there was no change in the female 
group. (Table: 10 & 11) 
Table: 10- Hyperprolactinemia- Male 
 
Male 
Aripiprazole       
(N= 9) 
Placebo  
(N = 6) 
HP Normal HP Normal 
 
Base line 
 
7 (77.8%) 
 
2 (22.2%) 
 
6 (100%) 
 
0 
 
 
End of 
8weeks 
 
2 (22.2%) 
 
7 (77.8%) 
 
6 (100%) 
 
0 
 
 
HP:Hyperprolactinemia 
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Table: 11- Hyperprolactinemia- Female. 
 
 
Female. 
Aripiprazole      (N= 6) Placebo (N = 9) 
 
HP. Normal. HP. Normal. 
 
 
Base line 
 
6 (100%) 
 
 
o 
 
9 (100%) 
 
0 
 
End of the 
study. 
 
6 (100%) 
 
 
0 
 
7 (100%) 
 
0 
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Prolactin related physical symptoms 
Findings of Arizona Sexual Experience Scale (AEEX) and 
Prolactin Related Adverse Events Questionnaire. (PRAEQ) 
There is no statistically significant difference between the scores at the 
baseline. 
Table: 12- Baseline difference between groups. 
 Mean SD Aripiprazole Placebo P 
ASEX 13.8 2.91 13.27(3.01) 14.33(2.82) 0.32 
PRAEQ 28.27 12.28 29.60(13.60) 26.93(11.11) 0.56 
 
At the end of 8 weeks there is significant difference in the ASEX total 
score but this difference was not noted in PRAEQ. 
Table 13- End of 8 weeks 
 Mean SD Aripiprazole Placebo P 
ASEX 12.86 3.027 11.73(2.99) 14.15(2.609) 0.032* 
PRAEQ 23.86 11.6 22.07(12.00) 25.92(11.37) 0.393 
*- Statistically significant. 
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In Aripiprazole group, there is statistically significant difference 
between the mean scores at the baseline and the end of the study, which 
means patients in the Aripiprazole group had improvement in their menstrual 
and sexual functions. (Table: 14) 
Table: 14- Reduction from the baseline- Aripiprazole group 
 Mean difference. t- value p- value 
PRAEQ - 7.533 -4.923 <0.001*+ 
ASEX -1.533 -2.78 0.015* 
 
However this difference is not noted in the placebo group as shown in 
the Table: 15  
Table: 15- Reduction from the baseline- Placebo group 
 Mean difference t- value p- value 
PRAEQ +0.231 +0.359 0.726 
ASEX _0.077 _0.158 0.877 
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Psychopathology ratings 
Baseline 
The mean BPRS and SAPS scores were less (9.3 and 4.23) indicating 
that our subjects had very minimal positive symptoms, on the other hand 
they had significant negative symptoms as scored by SANS. Their extra 
pyramidal symptoms were minimal as scored by SAES and none of them 
had any sign of akathisia. 
(Table: 16) There is no statically significant difference between two 
study groups in BPRS, SAPS, BARNES and SAES as indicated by their p 
values.  
Table: 16- Baseline clinical variables- Difference between study groups. 
 Total 
Mean 
SD Aripiprazole 
group. 
Mean(SD) 
Placebo 
group. 
Mean(SD) 
P Value 
SAPS 4.23 6.36 5.2(6.92) 3.27(5.82) 0.41 
SANS 25.7 12.14 22.53(10.81) 28.87 0.16 
BPRS 9.3 5.49 9.6(5.81) 9.00(5.33) 0.77 
BARNES 0 0 0 0  
SAES 3.5 1.75 3.27(2.052)) 3.73(1.438) 0.48 
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We did not find any difference between the aripiprazole group and the 
placebo group at the end of 8 weeks. (Table: 17).  
Table: 17- Difference between the study groups at the end of 8 Weeks. 
                                                                                                                                                           
                                               a- t = - 2.267, df (26) 
 
SAPS- Scale for Assessment of  Positive Symptoms: SANS- Scale for Assessment of Negative 
Symptoms; BPRS- Brief Psychiatric Rating Scale; BARNES- Barnes Akathisia Rating Scale; SAES- 
Simpson Angus Extra Pyramidal Symptoms Scale.                                                                                                                             
 
 Total 
Mean 
SD Aripiprazole 
group. 
Mean(SD) 
Placebo 
group. 
Mean(SD) 
Mean 
difference 
P value 
SAPS 4.39 7.026 6.6(8.65) 1.85(3.24) 4.754 0.073 
SANS 23.68 9.109 20.67(9.40) 27.15(7.69) 6.487 0.059 
BPRS 8.43 4.36 9.53(5.31) 7.15(2.54) 2.38 0.153 
BARNES 0 0 0 0 0  
SAES 3.29 1.58 3.00(1.732) 3.62(1.39) 0.615 0.599 
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Table: 18- Difference from the base line at the end of the study for 
Psychopathology variables 
 
 
 
Aripiprazole group 
 
 Placebo group 
 
 
 
Mean difference (SD) P value Mean difference (SD) P value 
SAPS + 1.4 (5.74) 0.361 _ 0.462 (0.97) 0.111 
SANS _ 1.86(5.902) 0.241 _ 1.538(3.99) 0.19 
BPRS _0.067 0.961 _0.615 0.321 
BARNES 0  0  
SAES _0.267 0.104 _0.077 0.721 
 
There is no statistically significant difference in clinical variables at 
the end of study from the base line in either group. (Table: 18) 
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Adverse effects 
1. Two patients from the Aripiprazole group reported worsening of 
psychotic symptoms after 2 weeks but they were clinically stable and 
were treated with Lorazepam.  
2. Two patients in the Aripiprazole group  developed symptoms 
suggestive of gastritis and was treated with proton pump blockers. 
3. One patient in the Aripiprazole group developed galactocoele, which 
was secondary to a traumatic injury, as evaluated by our surgery 
department.  
4. One patient in the placebo group developed insomnia which was 
transient and responded to short course of Benzodiazepines.  
5. One patient from placebo group developed fever with hepatitis during 
the last week of follow up and was diagnosed as infectious hepatitis. 
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DISCUSSION 
We studied adjunctive treatment with Aripiprazole for 
hyperprolactinemia induced by Risperidone and we conclude that there was 
a very significant reduction in prolactin levels over the 8 weeks in both 
males and females. They also had improvement in sexual functions. These 
benefits occurred without any change in their psychopathology and without 
any adverse effects. 
     Among neuroleptics, risperidone causes maximum raise in prolactin 
levels (21), but still there are only few studies addressing this issue. As we 
could not locate any publication similar to our study, we believe that this is 
the first randomized controlled study in studying the effects of adding 
aripiprazole to risperidone induced hyperprolactinemia. 
        We used reduction in prolactin level from the baseline as the primary 
outcome. Whether this reduction in prolactin levels would lead to clinically 
meaningful improvement in sexual side effects was evaluated with Arizona 
sexual experience scale and Prolactin Related Adverse Event questionnaire. 
Arizona sexual experience scale is a valid and reliable tool that is widely 
used for measuring sexual dysfunctions (47) but Prolactin Related adverse 
Event Questionnaire needs further validation. However it gives objective 
measurement of side effects related to hyperprolactinemia and it was very 
easy to administer and covers wide range of symptom profile. 
47 
 
Prolactin Level 
At the end of our study there is reduction in prolactin level in 
Aripiprazole group compared to placebo group which is statistically 
significant (p<0.001). There is 60.6% reduction in prolactin level from 
the baseline in Aripiprazole group.  
    This percentage change is noted in both the sexes at the end of 8 
weeks which is similar to findings replicated in another study (24). 
    In our sample, Risperidone had caused greater prolactin elevations in 
female patients than male patients, which was statistically significant.  We 
found 86.7% men and 100% women treated with Risperidone had 
hyperprolactinemia at the baseline and this findings support existing 
literature that Risperidone causes hyperprolactinemia in 90% of the patients.  
(22, 24) 
    At the end of 8 weeks, 77.8% male patients in Aripiprazole group 
became normal and none of the male patients in the placebo group 
normalized.  (Pearson chi square value is 8.750 with p = 0.003 which is 
statistically significant.) 
    However none of female patients in Aripiprazole and placebo group 
normalized at the end of the study even though there is statistically and 
clinically significant reduction in Aripiprazole group. 
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We hypothesize that the dose of Aripiprazole (10 mg) may not be 
enough for complete normalization in all female patients and some of the 
male patients. Shim et al, 2007 (24)  have used 15 mg and 30 mg of 
Aripiprazole given as adjuvant to Haloperidol to treat hyperprolactinemia. 
     But there is an open label trial (48) stating there is no significant 
reduction in serum prolactin level noted above 6 mg Aripiprazole. 
Adjunctive Aripiprazole was added to patients on risperidone and the 
Aripiprazole dose was gradually increased from 3 mg to 12 mg and serum 
prolactin was measured with each increase in the dose. It was found that 
reduction in prolactin level occurs with 3 mg of Aripiprazole and achieves a 
plateau at dosage beyond 6 mg.  
      In a randomized control Trial (49), Potkin et al compared Aripiprazole 
20 mg with Aripiprazole 30 mg. It was found out that both the Aripiprazole 
group has significant reduction in serum prolactin level from the base line. In 
the 20 mg group, mean reduction was 54. 5%. In 30 mg group, mean 
reduction was 50. 4 %. It was found that there is no statistically significant 
difference between 20 mg and 30 mg of Aripiprazole in terms of reduction in 
prolactin level. 
      It was also hypothesized that Aripiprazole if given for a longer 
duration in a low dose may normalize hyperprolactinemia. But this needs 
further research with frequent prolactin level measurement and different 
doses of Aripiprazole to confirm the hypothesis. 
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Prolactin related sexual side effects 
92% of female patients have menstrual disturbances at the baseline but 
chest symptoms were present in only 40% of the female patients. None of 
the male patients have chest symptoms as it is well known that it is rare in 
male population. (50). Almost all the male patients have disturbances in 
penile functions including erectile and ejaculatory dysfunction. 
      In our study it was found that there is statistically significant reduction 
in mean Arizona sexual Experience Scale and Prolactin Related Adverse 
Events Questionnaire in Aripiprazole group at the end of 8 weeks but this 
difference was not noted in placebo group. 
      This is similar to the findings replicated in an open label, naturalistic, 
multicenter trial with a sample size of 555, where they compared 
Aripiprazole with other atypical antipsychotic agents (51). Authors have 
found out there is statistically significant improvement in mean Arizona 
Sexual Experience Scale in Aripiprazole group at the end of 26 weeks; 
However in our study there is improvement as early as 8 weeks. 
      In female patients, clinically significant improvement in chest 
symptoms was observed in Aripiprazole group but very minimal 
improvement was noted in menstrual disturbances. 
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In male patients there was clinically significant improvement in 
erectile dysfunction in Aripiprazole group. 
There is no difference between the baseline demographic and clinical 
variables. Since we recruited patients who were maintaining well on 
Risperidone, our mean SAPS and BPRS scores were low (4.23 and 9.3). 
However our participants scored high on negative symptoms as indicated by 
mean SANS score (25. 7)  
       Since almost all the patients were taking Trihexyphenidyl along with 
Risperidone, mean score of Simpson Angus Extra Pyramidal symptoms 
Rating Scale was only 3.5 and the subjects were allowed to continue the 
Trihexyphenidyl and none of them experienced extrapyramidal symptoms 
during the study. None of our patients had akathisia at the baseline and at the 
end of 8 weeks.  
       At the end of 8 weeks, we found no significant change in 
psychopathology between the groups. None of the subjects required hospital 
admission or dose modification of Risperidone for the worsening of 
symptoms. 
      However we should be cautious since there are case reports of 
worsening of positive symptoms due to treatment with Aripiprazole 
especially when it is added with other antipsychotics. (52) (53) (54) 
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     There is reduction in mean SANS score in Aripiprazole group from 
the baseline but it was not statistically significant. This finding is similar to 
another study, where there is reduction in negative symptoms with 
adjunctive Aripiprazole treatment yet there is no statistically significant 
reduction (24). 
The subjects in our study were chronically ill and clinically stable 
patients. These characteristics of our study subjects may make it difficult to 
find further improvements in negative symptoms, especially in only 8 weeks. 
However formal study is warranted to study the role of Aripiprazole in 
treating negative symptoms as it is theoretically possible.  
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LIMITATIONS 
 
1. We calculated sample size only for the primary outcome but for sub 
group analysis our sample size may not be enough. 
2. Arizona Sexual Experience Scale and Prolactin Related Adverse Event 
Questionnaire are not validated for our Indian setting. 
3. Drug levels are not measured. 
4. Compliance to Risperidone as well as the study drugs were assumed; 
however to reduce non-compliance we followed them every two 
weeks and gave study drugs. 
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                                       CONCLUSION 
From our study, we conclude that with 8 weeks of adjunctive 
treatment of Aripiprazole in patients with Risperidone induced 
hyperprolactinemia, there are significant reductions in prolactin levels and 
even leads to normalization of hyperprolactinemia in some patients. 
There is clinical improvement in sexual side effects along with 
biochemical improvement. 
This method is safe and well tolerated and highly beneficial to 
individuals suffering from adverse effects because of hyperprolactinemia. 
However further studies are required to find out the optimal dose of 
Aripiprazole and duration to achieve the desired outcome. Further studies are 
required to find out the effects of Aripiprazole in psychopathology especially 
improvement in negative symptoms.  
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APPENDIX -I 
Supplementation of Aripiprazole in Risperidone induced hyperprolactinemia: A 
double blind Randomized placebo controlled trial. 
 
Date:       
OP NO:      
Name:          Age:  Sex: 
        
Marital status : Married    / Single  / Separate/divorced 
Monthly Income: 
Education  :    
Employment : 
 
Diagnosis: 
Events:  Prolactin level at the beginning of study 
Prolactin level  at  the end of  8 weeks 
Adverse events during past 2 weeks: 
2ND WEEK 
 
 
 
4TH WEEK 
 
 
 
6TH WEEK 
 
 
 
8TH WEEK 
 
 
 
 
Assessed by: 
 
  
 
 
 
 
 
 
 
APPENDIX -II 
 
INFORMED CONSENT 
  
Title of the study: A Double Blind Randomized Placebo controlled trial: Augmentation 
of Aripiprazole for Risperidone induced hyper prolactinemia.. 
  
Information to the participants: You are diagnosed to have schizophrenia 
maintaining on Risperidone. This medication you are taking for schizophrenia has 
the complication of hyper prolactinemia. There is possibility of long term side effects 
due to Risperidone induced hyper prolactinemia like decrease in bone mineral 
density and immediate complications like menstrual abnormality, sexual dysfunction 
according to available literature. Switching to other antipsychotic, there is possibility 
of relapse of symptoms of schizophrenia. So with available literature augmentation 
with Aripiprazole causes reduction in hyper prolactenemia and its complications. The 
Side effects of Aripiprazole are akathesia , hypersensitivity, insomnia which can be 
managed symptomatically and we are regularly monitoring for side effects during 
follow up. You will be randomly assigned to either Aripiprazole/placebo after base 
line prolactin assessment for which 3ml of blood sample will be taken. Neither you 
nor the primary investigators will know that to which group you actually belong to. 
You will be given Aripiprazole/placebo totally for 8 weeks. Follow up will be there 
every 2 weeks to objectively assess any side effects, improvement in symptoms and 
to collect the drugs for next 2 weeks. At the end of the study prolactin level is done 
again after collecting 3 ml of blood.  
  
Undertaking by the Investigator: Your consent to participate in the study is 
sought. You have the right to refuse consent or withdraw the same during any part of 
the study without giving any reason. In such instance you will still receive the best 
possible treatment, without any prejudice. If you have any doubts about the study, 
please feel free to clarify the same (phone numbers and contact addresses will be 
provided to you) at any time. All your records will be kept strictly confidential.  
 
 
Thesis student: Dr.R.Venkateswaran, ph- 9994474538 
Thesis guide: Dr.Raghuthaman.   
 
Consent: I have been informed about the procedures of the study. The possible 
risks too have been explained to me as stated above. I have understood that I have 
the right to refuse my consent or withdraw it any time during the study without 
adversely affecting my/my ward’s treatment. I have been provided ample time to ask 
questions and I Have been clarified to my satisfaction. I am also aware that by 
subjecting myself to this study, I will have to give more time for assessments by the 
doctor and that these assessments do not interfere with the benefits. 
  
I, …………………………, the undersigned, give my consent to be a participant of this 
study. 
  
SIGNATURE OF THE PATIENT/GUARDIAN:      SIGNATURE OF WITNESS: 
 NAME:                                                                     NAME: 
ADDRESS AND PHONE NUMBER:      
  
SIGNATURE OF THE DOCTOR: 
NAME: 
DESIGNATION: 
DATE: 
PLACE: 
 
 In case of Illiterates: I have been explained the contents of the informed consent in a 
language understandable to me and I am signing this document on my own. 
  
 
THUMB IMPRESSION                                THUMB IMPRESSION  
OF THE PATIENT:                                         OF THE WITNESS: 
 NAME:                                                              NAME:      
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  __ __ 2 
INTRODUCTION 
 
This scale is designed to assess positive symptoms, principally those that occur in schizophrenia.  It is intended to 
serve as a complementary instrument to the Scale for the Assessment of Negative Symptoms (SANS).  These 
positive symptoms include hallucinations, delusions, bizarre behavior, and positive formal thought disorder. 
 
As in the case of the SANS, the investigator using this instrument will need to decide on an appropriate "time set".  
The instrument was developed with the exception that, in general, the time set will cover the past month as in the 
case of SANS.  This scale can also be used in psychopharmacologic research in order to make weekly ratings 
and chart the subject's response to treatment. 
 
Investigators using this instrument, particularly in combination with the SANS, will need to use a standard clinical 
interview in order to evaluate the subject's symptoms.  Since positive formal thought disorder is an important 
positive symptom, it is recommended that, in doing this interview, the investigator begin talking with the subject on 
a relatively neutral topic for five to ten minutes in order to observe the subject's manner of speaking and 
responding.  Thereafter, he can begin to ask specific questions about the various positive symptoms.  Suggested 
probes are provided in the interview guide. 
 
In addition to using a clinical interview, the investigator should also draw on other sources of information, such as 
direct observation, reports from the subject's family, reports from nurses, and reports from the subject himself.  In 
general, the subject can usually be considered a relatively reliable informant concerning delusions and 
hallucinations if he is able to communicate clearly and will comply with a clinical interview.  On the other hand, the 
interviewer will usually have to rely on observation and reports from outside sources in order to evaluate bizarre 
behavior and positive formal thought disorder. 
 
The last item describing each major type of positive symptom is an overall global rating.  This should be a true 
global rating based on taking into account both the nature and the severity of the various types of symptoms 
observed.  In some cases, a single symptom (e.g., extremely severe persecutory delusions) may lead to a very 
high global rating, even if other symptoms of this type are not present. 
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HALLUCINATIONS 
 
Hallucinations represent an abnormality in perception.  They are false perceptions occurring in the absence of 
some identifiable external stimulus.  They may be experienced in any of the sensory modalities, including hearing, 
touch, taste, smell, and vision.  True hallucinations should be distinguished from illusions (which involve a 
misperception of an external stimulus), hypnogogic and hypnopompic experiences (which occur when the subject 
is falling asleep or waking up), or normal thought processes that are exceptionally vivid.  If the hallucinations have 
a religious quality, then they should be judged within the context of what is normal for the subject's social and 
cultural background.  Hallucinations occurring under the immediate influence of alcohol, drugs, or serious physical 
illness should not be rated as present.  The subject should always be requested to describe the hallucination in 
detail. 
 
Auditory Hallucinations 
The subject has reported voices, noises, or sounds.  The 
commonest auditory hallucinations involve hearing 
voices speaking to the subject or calling him names.  
The voices may be male or female, familiar or unfamiliar, 
and critical or complimentary.  Typically, subjects 
suffering from schizophrenia experience the voices as 
unpleasant and negative.  Hallucinations involving 
sounds rather than voices, such as noises or music, 
should be considered less characteristic and less severe. 
 
Have you ever heard voices or other sounds when no 
one is around? 
 
What did they say? 
None 0 SS36
 
Questionable 1 
 
Mild: Subject hears noises or single words; 
they occur only occasionally 2 
 
Moderate:  Clear evidence of voices; they 
have occurred at least weekly 3 
 
Marked:  Clear evidence of voices which 
occur almost every day 4 
 
Severe:  Voices occur often every day 5 
 
Voices Commenting 
Voices commenting are a particular type of auditory 
hallucination which phenomenologists as Kurt Schneider 
consider to be pathognomonic of schizophrenia, 
although some recent evidence contradicts this.  These 
hallucinations involve hearing a voice that makes a 
running commentary on the subject's behavior or thought 
as it occurs.  If this is the only type of auditory 
hallucination that the subject hears, it should be scored 
instead of auditory hallucinations (No. 1 above).  Usually, 
however, voices commenting will occur in addition to 
other types of auditory hallucinations. 
 
Have you ever heard voices commenting on what you 
are thinking or doing? 
 
What do they say? 
None 0 SS37
 
Questionable 1 
 
Mild: Subject hears noises or single words; 
they occur only occasionally 2 
 
Moderate:  Clear evidence of voices; they 
have occurred at least weekly 3 
 
Marked:  Clear evidence of voices which 
occur almost every day 4 
 
Severe:  Voices occur often every day 5 
 
 
  __ __ 4 
Voices Conversing 
Like voices commenting, voices conversing are 
considered a Schneiderian first-rank symptom.  They 
involve hearing two or more voices talking with one 
another, usually discussing something about the subject.  
As in the case of voices commenting, they should be 
scored independently of other auditory hallucinations. 
 
Have you heard two or more voices talking with each 
other? 
 
What did they say? 
None 0 SS38
 
Questionable 1 
 
Mild: Subject hears noises or single words; 
they occur only occasionally 2 
 
Moderate:  Clear evidence of voices; they 
have occurred at least weekly 3 
 
Marked:  Clear evidence of voices which 
occur almost every day 4 
 
Severe:  Voices occur often every day 5 
 
Somatic or Tactile Hallucinations 
These hallucinations involve experiencing peculiar 
physical sensations in the body.  They include burning 
sensations, tingling, and perceptions that the body has 
changed in shape or size. 
 
Have you ever had burning sensations or other strange 
feelings in your body? 
 
What were they? 
 
Did your body ever appear to change in shape or size? 
None 0 SS39
 
Questionable 1 
 
Mild: Subject experiences peculiar physical 
sensations; they occur only occasionally 2 
 
Moderate:  Clear evidence of somatic or 
tactile hallucinations; they have occurred at 
least weekly 3 
 
Marked:  Clear evidence of somatic or tactile 
hallucinations which occur almost every day 4 
 
Severe:  Hallucinations occur often every day 5 
 
Olfactory Hallucinations 
The subject experiences unusual smells which are 
typically quite unpleasant.  Sometimes the subject may 
believe that he himself smells.  This belief should be 
scored here if the subject can actually smell the odor 
himself, but should be scored among delusions if he only 
believes that others can smell the odor. 
 
Have you ever experienced any unusual smells or smells 
that others do not notice? 
 
What were they? 
None 0  SS40
 
Questionable 1 
 
Mild: Subject experiences unusual 
smells; they occur only occasionally 2 
 
Moderate:  Clear evidence of olfactory 
hallucinations; they have occurred at 
least weekly 3 
 
Marked:  Clear evidence of olfactory 
hallucinations; they occur almost every 
day 4 
 
Severe:  Olfactory hallucinations occur 
often every day 5 
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Visual Hallucinations 
The subject sees shapes or people that are not actually 
present.  Sometimes these are shapes or colors, but 
most typically they are figures of people or human-like 
objects.  They may also be characters of a religious 
nature, such as the Devil or Christ.  As always, visual 
hallucinations involving religious themes should be 
judged within the context of the subject's cultural 
background.  Hypnogogic and hypnopompic visual 
hallucinations (which are relatively common) should be 
excluded, as should visual hallucinations occurring when 
the subject has been taking hallucinogenic drugs. 
 
Have you had visions or seen things that other people 
cannot? 
 
What did you see? 
 
Did this occur when you were falling asleep or waking 
up? 
None 0  SS41
 
Questionable 1 
 
Mild: Subject experiences visual 
hallucinations; they occur only 
occasionally 2 
 
Moderate:  Clear evidence of visual 
hallucinations; they have occurred at 
least weekly 3 
 
Marked:  Clear evidence of visual 
hallucinations which occur almost every 
day 4 
 
Severe:  Hallucinations occur often every 
day 5 
 
Global Rating of Severity of Hallucinations 
This global rating should be based on the duration and 
severity of hallucinations, the extent of the subject's 
preoccupation with the hallucinations, his degree of 
conviction, and their effect on his actions.  Also consider 
the extent to which the hallucinations might be 
considered bizarre or unusual.  Hallucinations not 
mentioned above, such as those involving taste, should 
be included in this rating. 
None 0  SS42
 
Questionable 1 
 
Mild:  Hallucinations definitely present, 
but occur infrequently; at times the 
subject may question their existence 2 
 
Moderate:  Hallucinations are vivid and 
occur occasionally; they may bother him 
to some extent 3 
 
Marked:  Hallucinations are quite vivid, 
occur frequently, and pervade his life 4 
 
Severe:  Hallucinations occur almost daily 
and are sometimes unusual or bizarre; 
they are very vivid and extremely 
troubling 5 
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DELUSIONS 
 
Delusions represent an abnormality in content of thought.  They are false beliefs that cannot be explained on the 
basis of the subject's cultural background.  Although delusions are sometimes defined as "fixed false beliefs," in 
their mildest form delusions may persist only for weeks to months, and the subject may question his beliefs or 
doubt them.  The subject's behavior may or may not be influenced by his delusions.  The rating of severity of 
individual delusions and of the global severity of delusional thinking should take into account their persistence, 
their complexity, the extent to which the subject acts on them, the extent to which the subject doubts them, and the 
extent to which the beliefs deviate from those that normal people might have.  For each positive rating, specific 
examples should be noted in the margin. 
 
Persecutory Delusions 
People suffering from persecutory delusions believe that 
they are being conspired against or persecuted in some 
way.  Common manifestations include the belief that one 
is being followed, that one's mail is being opened, that 
one's room or office is bugged, that the telephone is 
tapped, or that police, government officials, neighbors, or 
fellow workers are harassing the subject.  Persecutory 
delusions are sometimes relatively isolated or 
fragmented, but sometimes the subject has a complex 
set of delusions involving both a wide range of forms of 
persecution and a belief that there is a well-designed 
conspiracy behind them.  For example, a subject may 
believe that his house is bugged and that he is being 
followed because the government wrongly considers him 
a secret agent for a foreign government; this delusion 
may be so complex that it explains almost everything that 
happens to him.  The ratings of severity should be based 
on duration and complexity. 
 
Have people been bothering you in any way? 
 
Have you felt that people are against you? 
 
Has anyone been trying to harm you in any way? 
 
Has anyone been watching or monitoring you? 
None 0  SS43
 
Questionable 1 
 
Mild:  Delusional beliefs are simple and may 
be of several different types; subject may 
question them occasionally 2 
 
Moderate:  Clear, consistent delusion that is 
firmly held 3 
 
Marked:  Consistent, firmly-held delusion 
that the subject acts on 4 
 
Severe:  Complex well-formed delusion that 
the subject acts on and that preoccupies him 
a great deal of the time; some aspects of the 
delusion or his reaction may seem quite 
bizarre 5 
 
Delusions of Jealousy 
The subject believes that his/her mate is having an affair 
with someone.  Miscellaneous bits of information are 
construed as "evidence".  The person usually goes to 
great effort to prove the existence of the affair, searching 
for hair in the bedclothes, the odor of shaving lotion or 
smoke on clothing, or receipts or checks indicating a gift 
has been bought for the lover.  Elaborate plans are often 
made in order to trap the two together. 
 
Have you ever worried that your husband (wife) might be 
unfaithful to you? 
 
What evidence do you have? 
None 0  SS44
 
Questionable 1 
 
Mild:  Delusion clearly present, but the 
subject may question it occasionally 2 
 
Moderate:  Clear consistent delusion that is 
firmly held 3 
 
Marked:  Consistent, firmly-held delusion 
that the subject acts on 4 
 
Severe:  Complex, well-formed delusion 
that the subject acts on and that 
preoccupies him a great deal of the time; 
some aspects of the delusion or his 
reaction may seem quite bizarre 5 
 
  __ __ 7 
Delusions of Sin or Guilt 
The subject believes that he has committed some 
terrible sin or done something unforgivable.  Sometimes 
the subject is excessively or inappropriately preoccupied 
with things he did wrong as a child, such as 
masturbating.  Sometimes the subject feels responsible 
for causing some disastrous event, such as a fire or 
accident, with which he in fact has no connection.  
Sometimes these delusions may have a religious flavor, 
involving the belief that the sin is unpardonable and that 
the subject will suffer eternal punishment from God.  
Sometimes the subject simply believes that he deserves 
punishment by society.  The subject may spend a good 
deal of time confessing these sins to whomever will 
listen. 
 
Have you ever felt that you have done some terrible 
thing that you deserve to be punished for? 
None 0  SS45
 
Questionable 1 
 
Mild:  Delusional beliefs may be simple and 
may be of several different types; subject 
may question them occasionally 2 
 
Moderate:  Clear, consistent delusion that is 
firmly held 3 
 
Marked:  Consistent, firmly-held delusion 
that the subject acts on 4 
 
Severe:  Complex, well-formed delusion 
that the subject acts on and that 
preoccupies him a great deal of the time; 
some aspects of the delusion or his 
reaction may seem quite bizarre 5 
 
Grandiose Delusions 
The subject believes that he has special powers or 
abilities.  He may think he is actually some famous 
personage, such as a rock star, Napoleon, or Christ.  He 
may believe he is writing some definitive book, 
composing a great piece of music, or developing some 
wonderful new invention.  The subject is often suspicious 
that someone is trying to steal his ideas, and he may 
become quite irritable if his ideas are doubted. 
 
Do you have any special or unusual abilities or talents? 
 
Do you feel you are going to achieve great things? 
None 0  SS46
 
Questionable 1 
 
Mild:  Delusional beliefs may be simple and 
may be of several different types; subject 
may question them occasionally 2 
 
Moderate:  Clear, consistent delusion that is 
firmly held 3 
 
Marked:  Consistent, firmly-held delusion 
that the subject acts on 4 
 
Severe:  Complex, well-formed delusion 
that the subject acts on and that 
preoccupies him a great deal of the time; 
some aspects of the delusion or his 
reaction may seem quite bizarre 5 
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Religious Delusions 
The subject is preoccupied with false beliefs of a 
religious nature.  Sometimes these exist within the 
context of a conventional religious system, such as 
beliefs about the Second Coming, the Antichrist, or 
possession by the Devil.  At other times, they may 
involve an entirely new religious system or a pastiche of 
beliefs from a variety of religions, particularly Eastern 
religions, such as ideas about reincarnation or Nirvana.  
Religious delusions may be combined with grandiose 
delusions (if the subject considers himself a religious 
leader), delusions of guilt, or delusions of being 
controlled.  Religious delusions must be outside the 
range considered normal for the subject's cultural and 
religious background. 
 
Are you a religious person? 
 
Have you had any unusual religious experiences? 
 
What was your religious training as a child? 
None 0  SS47
 
Questionable 1 
 
Mild:  Delusional beliefs may be simple and 
may be of several different types; subject 
may question them occasionally 2 
 
Moderate:  Clear, consistent delusion that is 
firmly held 3 
 
Marked:  Consistent, firmly-held delusion 
that the subject acts on 4 
 
Severe:  Complex, well-formed delusion 
that the subject acts on and that 
preoccupies him a great deal of the time; 
some aspects of the delusion or his 
reaction may seem quite bizarre 5 
 
Somatic Delusions 
The subject believes that somehow his body is diseased, 
abnormal, or changed.  For example, he may believe 
that his stomach or brain is rotting, that his hands or 
penis have become enlarged, or that his facial features 
are unusual (dysmorphophobia).  Sometimes somatic 
delusions are accompanied by tactile or other 
hallucinations, and when this occurs, both should be 
rated.  (For example, the subject believes that he has 
ballbearings rolling around in his head, placed there by a 
dentist who filled his teeth, and can actually hear them 
clanking against one another.) 
 
Is there anything wrong with your body? 
 
Have you noticed any change in your appearance? 
None 0  SS48
 
Questionable 1 
 
Mild:  Delusional beliefs may be simple and 
may be of several different types; subject 
may question them occasionally 2 
 
Moderate:  Clear, consistent delusion that is 
firmly held 3 
 
Marked:  Consistent, firmly-held delusion 
that the subject acts on 4 
 
Severe:  Complex, well-formed delusion 
that the subject acts on and that 
preoccupies him a great deal of the time; 
some aspects of the delusion or his 
reaction may seem quite bizarre 5 
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Ideas and Delusions of Reference 
The subject believes that insignificant remarks, 
statements, or events refer to him or have some special 
meaning for him.  For example, the subject walks into a 
room, sees people laughing, and suspects that they were 
just talking about him and laughing at him.  Sometimes 
items read in the paper, heard on the radio, or seen on 
television are considered to be special messages to the 
subject.  In the case of ideas of reference, the subject is 
suspicious, but recognizes his idea is erroneous.  When 
the subject actually believes that the statements or 
events refer to him, then this is considered a delusion of 
reference. 
 
Have you ever walked into a room and thought people 
were talking about you or laughing at you? 
 
Have you seen things in magazines or on TV that seem 
to refer to you or contain a special message for you? 
 
Have people communicated with you in any unusual 
ways? 
None 0  SS49
 
Questionable 1 
 
Mild:  Occasional ideas of reference 2 
 
Moderate:  Have occurred at least weekly 3 
 
Marked:  Occurs at least two to four times 
weekly 4 
 
Severe:  Occurs frequently 5 
 
Delusions of Being Controlled 
The subject has a subjective experience that his feelings 
or actions are controlled by some outside force.  The 
central requirement for this type of delusion is an actual 
strong subjective experience of being controlled.  It does 
not include simple beliefs or ideas, such as that the 
subject is acting as an agent of God or that friends or 
parents are trying to coerce him to do something.  
Rather, the subject must describe, for example, that his 
body has been occupied by some alien force that is 
making it move in peculiar ways, or that messages are 
being sent to his brain by radio waves and causing him 
to experience particular feelings that he recognizes are 
not his own. 
 
Have you ever felt you were being controlled by some 
outside force? 
None 0  SS50
 
Questionable 1 
 
Mild:  Subject has experienced being 
controlled, but doubts it occasionally 2 
 
Moderate:  Clear experience of control, 
which has occurred on two or three 
occasions in a week 3 
 
Marked:  Clear experience of control, 
which occurs frequently; behavior may be 
affected 4 
 
Severe:  Clear experience of control which 
occurs frequently, pervades the subject's 
life, and often affects his behavior 5 
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Delusions of Mind Reading 
The subject believes that people can read his mind or 
know his thoughts.  This is different than thought 
broadcasting (see below) in that it is a belief without a 
percept.  That is, the subject subjectively experiences 
and recognizes that others know his thoughts, but he 
does not think that they can be heard out loud. 
 
Have you ever had the feeling that people could read 
your mind? 
None 0  SS51
 
Questionable 1 
 
Mild:  Subject has experienced mind 
reading, but doubts it occasionally 2 
 
Moderate:  Clear experience of mind 
reading which has occurred on two or three 
occasions in a week 3 
 
Marked:  Clear experience of mind reading 
which occurs frequently; behavior may be 
affected 4 
 
Severe:  Clear experience of mind reading 
which occurs frequently, pervades the 
subject's life, and often affects his behavior 5 
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Thought Broadcasting 
The subject believes that his thoughts are broadcast so 
that he or others can hear them.  Sometimes the subject 
experiences his thoughts as a voice outside his head; 
this is an auditory hallucination as well as a delusion.  
Sometimes the subject feels his thoughts are being 
broadcast although he cannot hear them himself.  
Sometimes he believes that his thoughts are picked up 
by a microphone and broadcast on the radio or 
television. 
 
Have you ever heard your own thoughts out loud, as if 
they were a voice outside your head? 
 
Have you ever felt your thoughts were broadcast so 
other people could hear them? 
None 0  SS52
 
Questionable 1 
 
Mild:  Subject has experienced thought 
broadcasting, but doubts it occasionally 2 
 
Moderate:  Clear experience of thought 
broadcasting which has occurred on two or 
three occasions in a week 3 
 
Marked:  Clear experience of thought 
broadcasting which occurs frequently; 
behavior may be affected 4 
 
Severe:  Clear experience of thought 
broadcasting which occurs frequently, 
pervades the subject's life, and often 
affects his behavior 5 
 
Thought Insertion 
The subject believes that thoughts that are not his own 
have been inserted into his mind.  For example, the 
subject may believe that a neighbor is practicing voodoo 
and planting alien sexual thoughts in his mind.  This 
symptom should not be confused with experiencing 
unpleasant thoughts that the subject recognizes as his 
own, such as delusions of persecution or guilt. 
 
Have you ever felt that thoughts were being put into your 
head by some outside force? 
 
Have you ever experienced thoughts that didn't seem to 
be your own? 
None 0  SS53
 
Questionable 1 
 
Mild:  Subject has experienced thought 
insertion, but doubts it occasionally 2 
 
Moderate:  Clear experience of thought 
insertion which has occurred on two or 
three occasions in a week 3 
 
Marked:  Clear experience of thought 
insertion which occurs frequently; behavior 
may be affected 4 
 
Severe:  Thought insertion which occurs 
frequently, pervades the subject's life and 
affects behavior 5 
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Thought Withdrawal 
The subject believes that thoughts have been taken 
away from his mind.  He is able to describe a subjective 
experience of beginning a thought and then suddenly 
having it removed by some outside force.  This symptom 
does not include the mere subjective recognition of 
alogia. 
 
Have you ever felt your thoughts were taken away by 
some outside force? 
None 0  SS54
 
Questionable 1 
 
Mild:  Subject has experienced thought 
withdrawal, but doubts it occasionally 2 
 
Moderate:  Clear experience of thought 
withdrawal which has occurred on two or 
three occasions in a week 3 
 
Marked:  Clear experience of thought 
withdrawal which occurs frequently; 
behavior may be affected 4 
 
Severe:  Clear experience of thought 
withdrawal which occurs frequently, 
pervades the subject's life and often affects 
his behavior 5 
 
Global Rating of Severity of Delusions 
The global rating should be based on duration and 
persistence of delusions, the extent of the subject's 
preoccupation with the delusions, his degree of 
conviction, and their effect on his actions.  Also consider 
the extent to which the delusions might be considered 
bizarre or unusual.  Delusions not mentioned above 
should be included in this rating. 
None 0  SS55
 
Questionable 1 
 
Mild:  Delusion definitely present but, at 
times, the subject questions the belief 2 
 
Moderate:  The subject is convinced of the 
belief, but it may occur infrequently and 
have little effect on his behavior 3 
 
Marked:  The delusion is firmly held; it 
occurs frequently and affects the subject's 
behavior 4 
 
Severe:  Delusions are complex, well-
formed, and pervasive; they are firmly held 
and have a major effect on the subject's 
behavior; they may be somewhat bizarre or 
unusual 5 
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BIZARRE BEHAVIOR 
 
The subject's behavior is unusual, bizarre, or fantastic.  For example, the subject may urinate in a sugar bowl, 
paint the two halves of his body different colors, or kill a litter of pigs by smashing their heads against a wall.  The 
information for this item will sometimes come from the subject, sometimes from other sources, and sometimes 
from direct observation.  Bizarre behavior due to the immediate effects of alcohol or drugs should be excluded.  As 
always, social and cultural norms must be considered in making the ratings, and detailed examples should be 
elicited and noted. 
 
Clothing and Appearance 
The subject dresses in an unusual manner or does other 
strange things to alter his appearance.  For example, he 
may shave off all his hair or paint parts of his body 
different colors.  His clothing may be quite unusual; for 
example, he may choose to wear some outfit that 
appears generally inappropriate and unacceptable, such 
as a baseball cap backwards with rubber galoshes and 
long underwear covered by denim overalls.  He may 
dress in a fantastic costume representing some historical 
personage or a man from outer space.  He may wear 
clothing completely inappropriate to the climatic 
conditions, such as heavy wools in the midst of summer. 
 
Has anyone made comments about your appearance? 
None 0  SS56
 
Questionable 1 
 
Mild:  Occasional oddities of dress or 
appearance 2 
 
Moderate:  Appearance or apparel are 
clearly unusual and would attract attention 3 
 
Marked:  Appearance or apparel are 
markedly odd 4 
 
Severe:  Subject's appearance or apparel 
are very fantastic or bizarre 5 
 
Social and Sexual Behavior 
The subject may do things that are considered 
inappropriate according to usual social norms.  For 
example, he may masturbate in public, urinate or 
defecate in inappropriate receptacles, or exhibit his sex 
organs inappropriately.  He may walk along the street 
muttering to himself, or he may begin talking to people 
whom he has never met about his personal life (as when 
riding on a subway or standing in some public place).  He 
may drop to his knees praying and shouting in the midst 
of a crowd of people, or he may suddenly sit in a yoga 
position while in the midst of a crowd.  He may make 
inappropriate sexual overtures or remarks to strangers. 
 
Have you ever done anything that others might thing 
unusual or that has called attention to yourself? 
None 0  SS57
 
Questionable 1 
 
Mild:  Occasional instances of somewhat 
peculiar behavior 2 
 
Moderate:  Frequent instances of odd 
behavior 3 
 
Marked:  Very odd behavior 4 
 
Severe:  Extremely odd behavior which may 
have a fantastic quality 5 
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Aggressive and Agitated Behavior 
The subject may behave in an aggressive, agitated 
manner, often quite unpredictably.  He may start 
arguments inappropriately with friends or members of his 
family, or he may accost strangers on the street and 
begin haranguing them angrily.  He may write letters of a 
threatening or angry nature to government officials or 
others with whom he has some quarrel.  Occasionally, 
subjects may perform violent acts such as injuring or 
tormenting animals, or attempting to injure or kill human 
beings. 
 
Have you ever done anything to try to harm animals or 
people? 
 
Have you felt angry with anyone? 
 
How did you express your anger? 
None 0  SS58
 
Questionable 1 
 
Mild:  Occasional instances 2 
 
Moderate:  For example, writing angry 
letters to strangers 3 
 
Marked:  For example, threatening people, 
public harangues 4 
 
Severe:  For example, mutilating animals, 
attacking people 5 
Repetitive or Stereotyped Behavior 
The subject may develop a set of repetitive actions or 
rituals that he must perform over and over.  Frequently, 
he will attribute some symbolic significance to these 
actions and believe that they are either influencing others 
or preventing himself from being influenced.  For 
example, he may eat jelly beans every night for dessert, 
assuming that different consequences will occur 
depending on the color of the jelly beans.  He may have 
to eat foods in a particular order, wear particular clothes, 
or put them on in a certain order.  He may have to write 
messages to himself or to others over and over; 
sometimes this will be in an unusual or occult language. 
 
Are there any things that you feel you have to do? 
None 0  SS59
 
Questionable 1 
 
Mild:  Occasional instances of ritualistic or 
stereotyped behavior 2 
 
Moderate:  For example, eating or dressing 
rituals lacking symbolic significance 3 
 
Marked:  For example, eating or dressing 
rituals with a symbolic significance 4 
 
Severe:  For example, keeping a diary in an 
incomprehensible language 5 
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Global Rating of Severity of Bizarre Behavior 
In making this rating, the interviewer should consider the 
type of behavior, the extent to which it deviates from 
social norms, the subject's awareness of the degree to 
which the behavior is deviant, and the extent to which it 
is obviously bizarre. 
None 0  SS60
 
Questionable 1 
 
Mild:  Occasional instances of unusual or 
apparently idiosyncratic behavior; subject 
usually has some insight 2 
 
Moderate:  Behavior which is clearly 
deviant from social norms and seems 
somewhat bizarre; subject may have some 
insight 3 
 
Marked:  Behavior which is markedly 
deviant from social norms and clearly 
bizarre; subject may have some insight 4 
 
Severe:  Behavior which is extremely 
bizarre or fantastic; may include a single 
extreme act, e.g., attempting murder; 
subject usually lacks insight.  5 
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POSITIVE FORMAL THOUGHT DISORDER 
 
Positive formal thought disorder is fluent speech that tends to communicate poorly for a variety of reasons.  The 
subject tends to skip from topic to topic without warning, to be distracted by events in the nearby environment, to 
join words together because they are semantically or phonologically alike even though they make no sense, or to 
ignore the question asked and ask another.  This type of speech may be rapid, and it frequently seems quite 
disjointed.  It has sometimes been referred to as "loose associations."  Unlike alogia (negative formal thought 
disorder), a wealth of detail is provided, and the flow of speech tends to have an energetic, rather than an 
apathetic, quality to it. 
 
In order to evaluate thought disorder, the subject should be permitted to talk at length on some topic, particularly a 
topic unrelated to his psychopathology, for as long as five to ten minutes.  The interviewer should observe closely 
the extent to which his sequencing of ideas is well connected.  In addition, the interviewer should insist that he 
clarify or elaborate further if the ideas seem vague or incomprehensible.  He should also pay close attention to 
how well the subject can reply to a variety of different types of questions, ranging from simple (Where were you 
born?) to more complicated (How do you think the present government is doing?) 
 
The anchor points for these ratings assume that the subject has been interviewed for a total of approximately 
forty-five minutes.  If the interview is shorter, the ratings should be adjusted accordingly. 
 
Derailment (Loose Associations) 
A pattern of spontaneous speech in which the ideas slip 
off one track onto another which is clearly but obliquely 
related, or onto one which is completely unrelated.  
Things may be said in juxaposition which lack a 
meaningful relationship, or the subject may shift 
idiosyncratically from one frame of reference to another.  
At times there may be a vague connection between the 
ideas, and at others none will be apparent.  This pattern 
of speech is often characterized as sounding "disjointed."  
Perhaps the commonest manifestation of this disorder is 
a slow, steady slippage, with no single derailment being 
particularly severe, so that the speaker gets farther and 
farther off the track with each derailment without showing 
any awareness that his reply no longer has any 
connection with the question which was asked.  This 
abnormality is often characterized by lack of cohesion 
between clauses and sentences and by unclear pronoun 
references. 
 
Example:  Interviewer:  "Did you enjoy college?"  
Subject:  "Um-hum.  Oh hey well, I oh, I really enjoyed 
some communities I tried it, and the, and the next day 
when I'd be going out, you know, um, I took control like 
uh, I put, um, bleach on my hair in, in California.  My 
roommate was from Chicago, and she was going to the 
junior college.  And we lived in the Y.M.C.A., so she 
wanted to put it, um, peroxide on my hair, and she did, 
and I got up and looked at the mirror and tears came to 
my eyes.  Now do you understand it, I was fully aware of 
what was going on but why couldn't I, I . . . why, why the 
tears?  I can't understand that, can you?" 
None 0  SS61
 
Questionable 1 
 
Mild:  Occasional instances of derailment, 
with only slight topic shifts 2 
 
Moderate:  Several instances of derailment; 
subject is sometimes difficult to follow 3 
 
Marked:  Frequent instances of derailment; 
subject is often difficult to follow 4 
 
Severe:  Derailment so frequent and/or 
extreme that the subject's speech is almost 
incomprehensible 5 
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Tangentiality 
Replying to a question in an oblique, tangential or even 
irrelevant manner.  The reply may be related to the 
question in some distant way.  Or the reply may be 
unrelated and seem totally irrelevant.  In the past 
tangentiality has sometimes been used as roughly 
equivalent to loose associations or derailment.  The 
concept of tangentiality has been partially redefined so 
that it refers only to answers to questions and not to 
transitions in spontaneous speech. 
 
Example:  Interviewer:  "What city are you from?"  
Subject:  "That's a hard question to answer because my 
parents . . . I was born in Iowa, but I know that I'm white 
instead of black, so apparently I came from the North 
somewhere and I don't know where, you know, I really 
don't know whether I'm Irish or Scandinavian or I don't, I 
don't believe I'm Polish but I think I'm, I think I might be 
German or Welsh. 
None 0  SS62
 
Questionable 1 
 
Mild:  One or two oblique replies 2 
 
Moderate:  Occasional oblique replies 
(three to four times) 3 
 
Marked:  Frequent oblique replies (more 
than four times 4 
 
Severe:  Tangentiality so severe that 
interviewing the subject is extremely difficult 5 
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Incoherence (Word Salad, Schizophasia) 
A pattern of speech which is essentially 
incomprehensible at times.  Incoherence is often 
accompanied by derailment.  It differs from derailment in 
that in incoherence the abnormality occurs within the 
level of the sentence or clause, which contains words or 
phrases that are joined incoherently.  The abnormality in 
derailment involves unclear or confusing connections 
between larger units, such as sentences or clauses. 
 
This type of language disorder is relatively rare.  When it 
occurs, it tends to be severe or extreme, and mild forms 
are quite uncommon.  It may sound quite similar to 
Wernicke's aphasia or jargon aphasia, and in these 
cases the disorder should only be called incoherence 
when history and laboratory data exclude the possibility 
of a past stroke, and formal testing for aphasia is 
negative. 
 
Exclusions:  Mildly ungrammatical constructions or 
idiomatic usages characteristic of particular regional or 
ethnic backgrounds, lack of education, or low 
intelligence. 
 
Example:  Interviewer:  "What do you think about current 
political issues like the energy crisis?"  Subject:  "They're 
destroying too many cattle and oil just to make soap.  If 
we need soap when you can jump into a pool of water, 
and then when you go to buy your gasoline, my folks 
always thought they should, get pop but the best thing to 
get, is motor oil, and, money.  May, may as well go there 
and, trade in some, pop caps and, uh, tires, and tractors 
to group, car garages, so they can pull cars away from 
wrecks, is what I believed in." 
None 0  SS63
 
Questionable 1 
 
Mild:  Occasional instances of incoherence 2 
 
Moderate:  Frequent bursts of incoherence 3 
 
Marked:  At least half of the subject's 
speech is incomprehensible 4 
 
Severe:  Almost all of the subject's speech 
is incomprehensible 5 
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Illogicality 
A pattern of speech in which conclusions are reached 
which do not follow logically.  This may take the form of 
non-sequiturs (= it does not follow), in which the subject 
makes a logical inference between two clauses which is 
unwarranted or illogical.  It may take the form of faulty 
inductive inferences.  It may also take the form of 
reaching conclusions based on faulty premises without 
any actual delusional thinking. 
 
Exclusions:  Illogicality may either lead to or result from 
delusional beliefs.  When illogical thinking occurs within 
the context of a delusional system, it should be 
subsumed under the concept of delusions and not 
considered a separate phenomenon representing a 
different type of thinking disorder.  Illogical thinking which 
is clearly due to cultural or religious values or to 
intellectual deficit should also be excluded. 
 
Example:  "Parents are the people that raise you.  Any 
thing that raises you can be a parent.  Parents can be 
anything -- material, vegetable, or mineral -- that has 
taught you something.  Parents would be the world of 
things that are alive, that are there.  Rocks -- a person 
can look at a rock and learn something from it, so that 
would be a parent." 
None 0  SS64
 
Questionable 1 
 
Mild:  Occasional instances of illogicality 2 
 
Moderate:  Frequent instances of illogicality 
(three or four times) 3 
 
Marked:  Much of the subject's speech is 
illogical (more than four times) 4 
 
Severe:  Most of the subject's speech is 
illogical 5 
 
Circumstantiality 
A pattern of speech which is very indirect and delayed in 
reaching its goal idea.  In the process of explaining 
something, the speaker brings in many tedious details 
and sometimes makes parenthetical remarks.  
Circumstantial replies or statements may last for many 
minutes if the speaker is not interrupted and urged to get 
to the point.  Interviewers will often recognize 
circumstantiality on the basis of needing to interrupt the 
speaker in order to complete the process of history-
taking within an allotted time.  When not called 
circumstantial, these people are often referred to as 
"long-winded." 
 
Exclusions:  Although it may coexist with instances of 
poverty of content of speech or loss of goal, it differs 
from poverty of content of speech in containing 
excessive amplifying or illustrative detail and from loss of 
goal in that the goal is eventually reached if the person is 
allowed to talk long enough.  It differs from derailment in 
that the details presented are closely related to some 
particular goal or idea and that the particular goal or idea 
must be, by definition, eventually reached. 
None 0  SS65
 
Questionable 1 
 
Mild:  Occasional instances of 
circumstantiality 2 
 
Moderate:  Frequent instances of 
circumstantiality 3 
 
Marked:  At least half of subject's speech is 
circumstantial 4 
 
Severe:  Most of the subject's speech is 
circumstantial 5 
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Pressure of Speech 
An increase in the amount of spontaneous speech as 
compared to what is considered ordinary or socially 
customary.  The subject talks rapidly and is difficult to 
interrupt.  Some sentences may be left uncompleted 
because of eagerness to get on to a new idea.  Simple 
questions which could be answered in only a few words 
or sentences are answered at great length so that the 
answer takes minutes rather than seconds and indeed 
may not stop at all if the speaker is not interrupted.  Even 
when interrupted, the speaker often continues to talk.  
Speech tends to be loud and emphatic.  Sometimes 
speakers with severe pressure will talk without any social 
stimulation and talk even though no one is listening.  
When subjects are receiving phenothiazines or lithium, 
their speech is often slowed down by medication, and 
then it can be judged only on the basis of amount, 
volume, and social appropriateness.  If a quantitative 
measure is applied to the rate of speech, then a rate 
greater than 150 words per minute is usually considered 
rapid or pressured.  This disorder may be accompanied 
by derailment, tangentiality, or incoherence, but it is 
distinct from them. 
None 0 SS66
 
Questionable 1 
 
Mild:  Slight pressure of speech; some 
slight increase in amount, speed, or 
loudness of speech 2 
 
Moderate:  Usually takes several minutes to 
answer simple questions, may talk when no 
one is listening, and/or speaks loudly and 
rapidly 3 
 
Marked:  Frequently talks as much as three 
minutes to answer simple questions; 
sometimes begins talking without social 
stimulation; difficult to interrupt 4 
 
Severe:  Subject talks almost continually, 
cannot be interrupted at all, and/or may 
shout to drown out the speech of others 5 
 
Distractible Speech 
During the course of a discussion or interview, the 
subject stops talking in the middle of a sentence or idea 
and changes the subject in response to a nearby 
stimulus, such as an object on a desk, the interviewer's 
clothing or appearance, etc. 
 
Example:  "Then I left San Francisco and moved to . . . 
where did you get that tie?  It looks like it's left over from 
the 50's.  I like the warm weather in San Diego.  Is that a 
conch shell on your desk?  Have you ever gone scuba 
diving? 
None 0  SS67
 
Questionable 1 
 
Mild:  Is distracted once during an 
interview 2 
 
Moderate:  Is distracted from two to four 
times during an interview 3 
 
Marked:   Is distracted from five to ten 
times during an interview 4 
 
Severe:  Is distracted more than ten times 
during an interview 5 
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Clanging 
A pattern of speech in which sounds rather than 
meaningful relationships apear to govern word choice, so 
that the intelligibility of the speech is impaired and 
redundant words are introduced.  In addition to rhyming 
relationships, this pattern of speech may also include 
punning associations, so that a word similar in sound 
brings in a new thought. 
 
Example:  I'm not trying to make a noise.  I'm trying to 
make sense.  If you can make sense out of nonsense, 
well, have fun.  I'm trying to make sense out of sense.  
I'm not making sense (cents) anymore.  I have to make 
dollars." 
None 0  SS68
 
Questionable 1 
 
Mild:  Occurs once during an interview 2 
 
Moderate:  Occurs from two to four times 
during an interview 3 
 
Marked:  Occurs five to ten times during 
an interview 4 
 
Severe:  Occurs more than ten times, or 
so frequently that the interview is 
incomprehensible. 
 
Global Rating of Positive Formal Thought Disorder 
In making this rating, the interviewer should consider the 
type of abnormality, the degree to which it affects the 
subject's ability to communicate, the frequency with 
which abnormal speech occurs, and its degree of 
severity. 
None 0  SS69
 
Questionable 1 
 
Mild:  Occasional instances of disorder; 
subject's speech is understandable 2 
 
Moderate:  Frequent instances of disorder; 
subject is sometimes hard to understand 3 
 
Marked:  Subject is often difficult to 
understand 4 
 
Severe:  Subject is incomprehensible 5 
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AFFECTIVE FLATTENING OR BLUNTING 
 
Affective flattening or blunting manifests itself as a characteristic impoverishment of emotional expression, reactivity, 
and feeling.  Affective flattening can be evaluated by observation of the subject's behavior and responsiveness 
during a routine interview.  The rating of some items may be affected by drugs, since the Parkinsonian side-effect of 
phenothiazines may lead to mask-like facies and diminished associated movements.  Other aspects of affect, such 
as responsivity or appropriateness, will not be affected, however. 
 
Unchanging Facial Expression 
The subject's face appears wooden, mechanical, 
frozen.  It does not change expression, or 
changes less than normally expected, as the 
emotional content of discourse changes.  Since 
phenothiazines may partially mimic this effect, 
the interviewer should be careful to note whether 
or not the subject is on medication, but should 
not try to "correct" the rating accordingly. 
 
Not at all:  Subject is normal or labile 0 SS11 
 
Questionable decrease 1 
 
Mild:  Occasionally the subject's 
expression is not as full as expected 2 
 
Moderate:  Subject's expressions are 
dulled overall, but not absent 3 
 
Marked:  Subject's face has a flat "set" 
look, but flickers of affect arise 
occasionally 4 
 
Severe:  Subject's face looks "wooden" 
and changes little, if at all throughout 
the interview 5 
 
 
Decreased Spontaneous Movements 
The subject sits quietly throughout the interview 
and shows few or no spontaneous movements.  
He does not shift position, move his legs, move 
his hands, etc., or does so less than normally 
expected. 
Not at all:  Subject moves normally or is 
overactive 0  SS12 
 
Questionable decrease 1 
 
Mild:  Some decrease in spontaneous 
movements 2 
 
Moderate:  Subject moves three or four 
times during the interview 3 
 
Marked:  Subject moves once or twice 
during the interview 4 
 
Severe:  Subject sits immobile 
throughout the interview 5 
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Paucity of Expressive Gestures 
The subject does not use his body as an aid in 
expressing his ideas, through such means as 
hand gestures, sitting forward in his chair when 
intent on a subject, leaning back when relaxed, 
etc.  This may occur in addition to decreased 
spontaneous movements. 
Not at all:  Subject uses expressive 
gestures normally or excessively 0  SS13 
 
Questionable decrease 1 
 
Mild:  Some decrease in expressive 
gestures 2 
 
Moderate:  Subject uses body as an aid 
in expression at least three or four times 3 
 
Marked:  Subject uses body as an aid in 
expression only once or twice 4 
 
Severe:  Subject never uses body as an 
aid in expression 5 
 
 
Poor Eye Contact 
The subject avoids looking at others or using his 
eyes as an aid in expression.  He appears to be 
staring into space even when he is talking. 
Not at all:  Good eye contact and 
expression 0  SS14 
 
Questionable decrease 1 
 
Mild:  Some decrease in eye contact and 
eye expression 2 
 
Moderate:  Subject's eye contact is 
decreased by at least half of normal 3 
 
Marked:  Subject's eye contact is very 
infrequent 4 
 
Severe:  Subject almost never looks at 
interviewer 5 
 
 
Affective Nonresponsivity 
Failure to smile or laugh when prompted may be 
tested by smiling or joking in a way which would 
usually elicit a smile from a normal individual.  
The examiner may also ask, "Have you forgotten 
how to smile?" while smiling himself. 
Not at all 0  SS15 
 
Questionable decrease 1 
 
Mild:  Slight but definite lack in 
responsivity 2 
 
Moderate:  Subject occasionally seems 
to miss the cues to respond  3 
 
Marked:  Subject seems to miss the 
cues to respond most of the time 4 
 
Severe:  Subject is essentially 
unresponsive, even on prompting 5 
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Lack of Vocal Inflections 
While speaking the subject fails to show normal 
vocal emphasis patterns.  Speech has a 
monotonic quality, and important words are not 
emphasized through changes in pitch or volume.  
Subject also may fail to change volume with 
changes of subject so that he does not drop his 
voice when discussing private topics nor raise it 
as he discusses things which are exciting or for 
which louder speech might be appropriate. 
 
 
 
 
 
Global Rating of Affective Flattening 
The global rating should focus on overall severity 
of affective flattening or blunting.  Special 
emphasis should be given to such core features 
as unresponsiveness, inappropriateness, and an 
overall decrease in emotional intensity. 
Not all all:  Normal vocal inflections 0 SS16 
 
Questionable decrease 1 
 
Mild:  Slight decrease in vocal inflections 2 
 
Moderate:  Interviewer notices several 
instances of flattened vocal inflections 3 
 
Marked:  Obvious decrease in vocal 
inflections 4 
 
Severe:  Subject's speech is a 
continuous monotone 5 
 
 
 
No flattening:  Normal affect 0 SS17 
 
Questionable affective flattening 1 
 
Mild affective flattening 2 
 
Moderate affective flattening 3 
 
Marked affective flattening 4 
 
Severe affective flattening 5 
 
 
Inappropriate Affect 
Affect expressed is inappropriate or 
incongruous, not simply flat or blunted.  Most 
typically, this manifestation of affective 
disturbance takes the form of smiling or 
assuming a silly facial expression while talking 
about a serious or sad subject.  (Occasionally 
subjects may smile or laugh when talking about 
a serious subject which they find uncomfortable 
or embarrassing.  Although their smiling may 
seem inappropriate, it is due to anxiety and 
therefore should not be rated as inappropriate 
affect.)  Do not rate affective flattening or 
blunting as inappropriate. 
 
 
 
 
Not at all:  Affect is not inappropriate 0   SS18 
 
Questionable 1 
 
Mild:  At least one instance of 
inappropriate smiling or other 
inappropriate affect 2 
 
Moderate:  Subject exhibits two to four 
instances of inappropriate affect 3 
 
Marked:  Subject exhibits five to ten 
instances of inappropriate affect 4 
 
Severe:  Subject's affect is inappropriate 
most of the time 5 
 
 
   __ __5 
 
ALOGIA 
 
Alogia is a general term coined to refer to the impoverished thinking and cognition that often occur in subjects with 
schizophrenia (Greek a = no, none; logos = mind, thought).  Subjects with alogia have thinking processes that seem 
empty, turgid, or slow.  Since thinking cannot be observed directly, it is inferred from the subject's speech.  The two 
major manifestations of alogia are nonfluent empty speech (poverty of speech) and fluent empty speech (poverty of 
content of speech).  Blocking and increased latency or response may also reflect alogia. 
 
Poverty of Speech 
Restriction in the amount of spontaneous 
speech, so that replies to questions tend to be 
brief, concrete, and unelaborated.  
Unprompted additional information is rarely 
provided.  Replies may be monosyllabic, and 
some questions may be left unanswered 
altogether.  When confronted with this speech 
pattern, the interviewer may find himself 
frequently prompting the subject in order to 
encourage elaboration of replies.  To elicit this 
finding, the examiner must allow the subject 
adequate time to answer and to elaborate his 
answer. 
No poverty of speech:  A substantial and 
appropriate number of replies to questions include 
additional information 0 SS19 
 
Questionable poverty of speech 1 
 
Mild:  Occasional replies do not include elaborated 
information even though this is appropriate 2 
 
Moderate:  Some replies do not include 
appropriately elaborated information, and some 
replies are monosyllabic or very brief--("Yes."  
"No."  "Maybe."  "I don't know."  "Last week.") 3 
 
Marked:  Answers are rarely more than a sentence 
or a few words in length 4 
 
Severe:  Subject says almost nothing and 
occasionally fails to answer questions 5 
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Poverty of Content of Speech 
Although replies are long enough so that speech 
is adequate in amount, it conveys little 
information.  Language tends to be vague, often 
over-abstract or over-concrete, repetitive, and 
stereotyped.  The interviewer may recognize this 
finding by observing that the subject has spoken 
at some length but has not given adequate 
information to answer the question.  
Alternatively, the subject may provide enough 
information, but require many words to do so, so 
that a lengthy reply can be summarized in a 
sentence or two.  Sometimes the interviewer 
may characterize the speech as "empty 
philosophizing." 
 
Exclusions:  This finding differs from 
circumstantiality in that the circumstantial subject 
tends to provide a wealth of detail. 
 
Example:  Interviewer:  "Why is it, do you think, 
that people believe in God?"  Subject:  "Well, 
first of all because he uh, he are the person that 
is their personal savior.  He walks with me and 
talks with me.  And uh, the understanding that I 
have, um, a lot of peoples, they don't really, uh, 
know they own personal self.  Because, uh, they 
ain't, they all, just don't know they personal self.  
They don't, know that he uh, seemed like to me, 
a lot of 'em don't understand that he walks and 
talks with them." 
No poverty of content 0 SS20
 
Questionable 1 
 
Mild:  Occasional replies are too vague 
to be comprehensible or can be 
markedly condensed 2 
 
Moderate:  Frequent replies which are 
vague or can be markedly condensed 
to make up at least a quarter of the 
interview 3 
 
Marked:  At least half of the subject's 
speech is composed of vague or 
incomprehensible replies 4 
 
Severe:  Nearly all the speech is vague, 
incomprehensible, or can be markedly 
condensed 5 
 
 
Blocking 
Interruption of a train of speech before a thought 
or idea has been completed.  After a period of 
silence which may last from a few seconds to 
minutes, the person indicates that she/he cannot 
recall what he had been saying or meant to say.  
Blocking should only be judged to be present if a 
person voluntarily describes losing his thought or 
if, upon questioning by the interviewer, the 
person indicates that that was the reason for 
pausing. 
No blocking 0 SS21
 
Questionable 1 
 
Mild:  A single instance noted during a 
forty-five minute period 2 
 
Moderate:  Occurs twice during forty-five 
minutes 3 
 
Marked:  Occurs three or four times 
during forty-five minutes 4 
 
Severe:  Occurs more than four times in 
forty-five minutes 5 
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Increased Latency of Response 
The subject takes a longer time to reply to questions 
than is usually considered normal.  He may seem 
"distant" and sometimes the examiner may wonder if 
he has even heard the question.  Prompting usually 
indicates that the subject is aware of the question, 
but has been having difficulty in formulating his 
thoughts in order to make an appropriate reply. 
Not at all 0 SS22
Questionable 1 
Mild:  Occasional brief pauses before 
replying 2 
Moderate:  Often pauses several seconds 
before replying 3 
Marked:  Usually pauses at least ten to 
fifteen seconds before replying 4 
Severe:  Long pauses prior to nearly all 
replies. 5 
 
Global Rating of Alogia 
Since the core features of alogia are poverty of 
speech and poverty of content of speech, the global 
rating should place particular emphasis on them. 
No alogia 0 SS23
Questionable 1 
Mild:  Mild but definite impoverishment in 
thinking 2 
Moderate:  Significant evidence for 
impoverished thinking 3 
Marked:  Subject's thinking seems 
impoverished much of the time 4 
Severe:  Subject's thinking seems 
impoverished nearly all of the time 5 
 
AVOLITION-APATHY 
 
Avolition manifests itself as a characteristic lack of energy, drive, and interest.  Subjects are unable to mobilize 
themselves to initiate or persist in completing many different kinds of tasks.  Unlike the diminished energy or interest 
of depression, the avolitional symptom complex in schizophrenia is usually not accompanied by saddened or 
depressed affect.  The avolitional symptom complex often leads to severe social and economic impairment. 
 
Grooming and Hygiene 
The subject displays less attention to grooming 
and hygiene than normal.  Clothing may appear 
sloppy, outdated, or soiled.  The subject may bathe 
infrequently and not care for hair, nails, or teeth--
leading to such manifestations as greasy or 
uncombed hair, dirty hands, body odor, or unclean 
teeth and bad breath.  Overall, the appearance is 
dilapidated and disheveled.  In extreme cases, the 
subject may even have poor toilet habits. 
 
How often do you bathe or shower? 
 
Do you change your clothes every day? 
 
How often do you do laundry? 
No evidence of poor grooming and 
hygiene 0 SS24
 
Questionable 1 
 
Mild:  Some slight but definite indication of 
inattention to appearance, i.e., messy hair 
or disheveled clothes 2 
 
Moderate:  Appearance is somewhat 
disheveled, i.e., greasy hair, dirty clothes 3 
 
Marked:  Subject's attempts to keep up 
grooming or hygiene are minimal 4 
 
Severe:  Subject's clothes, body and 
environment are dirty and smelly 5 
 
 
Impersistence at Work or School 
The subject has had difficulty in seeking or maintaining No evidence of impersistence at work 
   __ __8 
employment (or schoolwork) as appropriate for his or 
her age and sex.  If a student, he/she does not do 
homework and may even fail to attend class.  Grades 
will tend to reflect this.  If a college student, there may 
be a pattern of registering for courses, but having to 
drop several or all of them before the semester is 
completed.  If of working age, the subject may have 
found it difficult to work at a job because of inability to 
persist in completing tasks and apparent 
irresponsibility.  He may go to work irregularly, wander 
away early, complete them in a disorganized manner.  
He may simply sit around the house and not seek any 
employment or seek it only in an infrequent and 
desultory manner.  If a housewife or retired person, the 
subject may fail to complete chores, such as shopping 
or cleaning, or complete them in an apparently 
careless and half-hearted way. 
 
Have you been having any problems at (work, school)? 
 
Do you ever start some project and just never get 
around to finishing it? 
or school 0 SS25
 
Questionable 1 
 
Mild:  Slight indications of 
impersistence, i.e., missing a couple 
days of school or work 2 
 
Moderate:  Subject often has poor 
performance at work or school 3 
 
Marked:  Subject has much difficulty 
maintaining even a below normal level 
of work or school 4 
 
Severe:  Subject consistently fails to 
maintain a record at work or school 5 
 
Physical Anergia 
The subject tends to be physically inert.  He may sit in a 
chair for hours at a time and not initiate any 
spontaneous activity.  If encouraged to become involved 
in an activity, he may participate only briefly and then 
wander away or disengage himself and return to sitting 
alone.  He may spend large amounts of time in some 
relatively mindless and physically inactive task such as 
watching TV or playing solitaire.  His family may report 
that he spends most of his time at home "doing nothing 
except sitting around".  Either at home or in an inpatient 
setting he may spend much of his time sitting in his 
room. 
 
Are there times when you lie or sit around most of the 
day? 
 
(Does this ever last longer than one day?) 
No Evidence of Physical Anergia 0 SS26
 
Questionable 1 
 
Mild Anergia 2 
 
Moderate:  Subject lies in bed or sits 
immobile at least a quarter of normal 
waking hours 3 
 
Marked:  Subject lies in bed or sits 
immobile at least half of normal 
waking hours 4 
 
Severe:  Subject lies in bed or sits 
immobile for most of the day 5 
 
Global Rating of Avolition - Apathy 
The global rating should reflect the overall severity of 
the avolition symptoms, given expectational norms for 
the subject's age and social status or origin.  In making 
the global rating, strong weight may be given to only 
one or two prominent symptoms if they are particularly 
striking. 
No Avolition 0 SS27
 
Questionable 1 
 
Mild, But Definitely Present 2 
 
Moderate Avolition 3 
 
Marked Avolition 4 
 
Severe Avolition 5 
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ANHEDONIA-ASOCIALITY 
 
This symptom complex encompasses the schizophrenic subject's difficulties in experiencing interest or pleasure.  It 
may express itself as a loss of interest in pleasurable activities, an inability to experience pleasure when participating 
in activities normally considered pleasurable, or a lack of involvement in social relationships of various kinds. 
 
Recreational Interests and Activities 
The subject may have few or no interests, 
activities, or hobbies.  Although this symptom 
may begin insidiously or slowly, there will usually 
be some obvious decline from an earlier level of 
interest and activity.  Subjects with relatively 
milder loss of interest will engage in some 
activities which are passive or non-demanding, 
such as watching TV, or will show only 
occasional or sporadic interest.  Subjects with 
the most extreme loss will appear to have a 
complete and intractible inability to become 
involved in or enjoy activities.  The rating in this 
area should take both the quality and quantity of 
recreational interests into account. 
 
Have you felt interested in the things you usually 
enjoy? 
 
(Have they been as fun as usual?) 
 
Have you been watching TV or listening to the 
radio? 
No Inability to Enjoy Recreational 
Interests or Activities 0 SS28
 
Questionable 1 
 
Mild Inability to Enjoy Recreational 
Activities 2 
 
Moderate:  Subject often is not "up" for 
recreational activities 3 
 
Marked:  Subject has little interest in and 
derives only mild pleasure from 
recreational activities 4 
 
Severe:  Subject has no interest in and 
derives no pleasure from recreational 
activities 5 
 
Sexual Interest and Activity 
The subject may show a decrement in sexual 
interest and activity, as judged by what would be 
normal for the subject's age and marital status.  
Individuals who are married may manifest 
disinterest in sex or may engage in intercourse 
only at the partner's request.  In extreme cases, 
the subject may not engage in any sex at all.  
Single subjects may go for long periods of time 
without sexual involvement and make no effort to 
satisfy this drive.  Whether married or single, 
they may report that they subjectively feel only 
minimal sex drive or that they take little 
enjoyment in sexual intercourse or in 
masturbatory activity even when they engage in 
it. 
 
Have you noticed any changes in your sex 
drive? 
No Inability to Enjoy Sexual Activities 0 SS29
 
Questionable Decrement in Sexual 
Interest and Activity 1 
 
Mild Decrement in Sexual Interest and 
Activity 2 
 
Moderate:  Subject occasionally has 
noticed decreased interests in and/or 
enjoyment from sexual activities 3 
 
Marked:  Subject has little interest in 
and/or derives little pleasure from sexual 
activities 4 
 
Severe:  Subject has no interest in 
and/or derives no pleasure from sexual 
activities 5 
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Ability to Feel Intimacy and Closeness 
The subject may display an inability to form close 
and intimate relationships of a type appropriate for 
his age, sex, and family status.  In the case of a 
younger person, this area should be rated in terms 
of relationships with the opposite sex and with 
parents and siblings.  In the case of an older person 
who is married, the relationship with spouse and 
with children should be evaluated, while older 
unmarried individuals should be judged in terms of 
relationships with the opposite sex and any family 
members who live nearby.  Subjects may display 
few or no feelings of affection to available family 
members.  Or they may have arranged their lives so 
that they are completely isolated from any intimate 
relationships, living alone and making no effort to 
initiate contacts with family or members of the 
opposite sex. 
 
Have you been having any problems with your 
(family, spouse)? 
 
How would you feel about visiting with your (family, 
parents, spouse, etc.)? 
No Inability to Feel Intimacy and 
Closeness 0 SS30
Questionable Inability 1 
Mild, But Definite Inability to Feel Intimacy 
and Closeness 2 
Moderate:  Subject appears to enjoy family 
or significant others but does not appear to 
"look forward" to visits 3 
Marked:  Subject appears neutral toward 
visits from family or significant others.  
Brightens only mildly 4 
Severe:  Subject prefers no contact with or 
is hostile toward family or significant others 5 
 
Relationships with Friends and Peers 
Subjects may also be relatively restricted in their 
relationships with friends and peers of either sex.  
They may have few or no friends, make little or no 
effort to develop such relationships, and choose to 
spend all or most of their time alone. 
 
Have you been spending much time with friends? 
 
Do you enjoy spending time alone, or would you 
rather have more friends? 
No Inability to Form Close Friendships 0 SS31
Questionable Inability to Form Friendships 1 
Mild, But Definite Inability to Form 
Friendships 2 
Moderate:  Subject able to interact, but 
sees friends/acquaintances only two to 
three times per month 3 
Marked:  Subject has difficulty forming 
and/or keeping friendships.  Sees 
friends/acquaintances only one to two 
times per month 4 
Severe:  Subject has no friends and no 
interest in developing any social ties 5 
 
Global Rating of Anhedonia-Asociality 
The global rating should reflect the overall severity 
of the anhedonia-asociality complex, taking into 
account the norms appropriate for the subject's 
age, sex, and family status. 
No Evidence of Anhedonia-Asociality 0 SS32
Questionable Evidence of Anhedonia-
Asociality 1 
Mild, But Definite Evidence of Anhedonia-
Asociality 2 
Moderate Evidence of Anhedonia-Asociality 3 
Marked Evidence of Anhedonia-Asociality 4 
Severe Evidence of Anhedonia-Asociality 5 
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ATTENTION 
 
Attention is often poor in schizophrenics.  The subject may have trouble focusing his attention, or he may only be 
able to focus sporadically and erratically.  He may ignore attempts to converse with him, wander away while in the 
middle of an activity or task, or appear to be inattentive when engaged in formal testing or interviewing.  He may or 
may not be aware of his difficulty in focusing his attention. 
 
Social Inattentiveness 
While involved in social situations or activities, 
the subject appears inattentive.  He looks away 
during conversations, does not pick up the topic 
during a discussion, or appears uninvolved or 
unengaged.  He may abruptly terminate a 
discussion or a task without any apparent 
reason.  He may seem "spacy" or "out of it".  He 
may seem to have poor concentration when 
playing games, reading, or watching TV. 
No Indication of Inattentiveness 0 SS33
 
Questionable Signs 1 
 
Mild, But Definite Signs of 
Inattentiveness 2 
 
Moderate:  Subject occasionally misses 
what is happening in the environment 3 
 
Marked:  Subject often misses what is 
happening in the environment; has 
trouble with reading comprehension 4 
 
Severe:  Subject unable to follow 
conversation, remember what he's read, 
or follow TV plot 5 
 
Inattentiveness During Mental Status Testing 
The subject may perform poorly on simple tests 
of intellectual functioning in spite of adequate 
education and intellectual ability.  This should be 
assessed by having the subject spell "world" 
backwards and by serial 7's (at least a tenth 
grade education) or serial 3's (at least a sixth 
grade education) for a series of five subtractions.  
A perfect score is 10. 
No Errors 0 SS34
 
Questionable:  No errors but subject 
performs in a halting manner or 
makes/corrects an error 1 
 
Mild, But Definite (One Error) 2 
 
Moderate (Two Errors) 3 
 
Marked (Three Errors) 4 
 
Severe (More Than Three Errors) 5 
 
Global Rating of Attention 
This rating should assess the subject's overall 
ability to attend or concentrate, and include both 
clinical appearance and performance on tasks. 
No Indications of Inattentiveness 0 SS35
 
Questionable 1 
 
Mild, But Definite Inattentiveness 2 
 
Moderate Inattentiveness 3 
 
Marked Inattentiveness 4 
 
Severe Inattentiveness 5 
 
 
 
  
 
 
 
 
 
 
 
 
APPENDIX -V 
 
 
Brief Psychiatric Rating Scale (BPRS)
Expanded Version (4.0)
Introduction
This section reproduces an interview schedule, symptom definitions, and specific anchor 
points for rating symptoms on the BPRS. Clinicians intending to use the BPRS should 
also consult the detailed guidelines for administration contained in the reference below. 
Scale Items and Anchor Points
Rate items 1-14 on the basis of individual's self-report. Note items 7, 12 and 13 are also 
rated on the basis of observed behaviour. Items 15-24 are rated on the basis of
observed behaviour and speech.
1. Somatic Concern
Degree of concern over present bodily health. Rate the degree to which physical health 
is perceived as a problem by the individual, whether complaints have realistic bases or 
not. Somatic delusions should be rated in the severe range with or without somatic 
concern. Note: be sure to assess the degree of impairment due to somatic concerns only 
and not other symptoms, e.g., depression. In addition, if the individual rates 6 or 7 due to 
somatic delusions, then you must rate Unusual Thought Content at least 4 or above. 
2 Very mild Occasional somatic concerns that tend to be kept to self. 
3 Mild Occasional somatic concerns that tend to be voiced to others (e.g., family, 
doctor).
4 Moderate Frequent expressions of somatic concern or exaggerations of existing ills 
OR some preoccupation, but no impairment in functioning. Not delusional. 
5 Moderately severe Frequent expressions of somatic concern or exaggerations of 
existing ills OR some preoccupation and moderate impairment of functioning. Not
delusional.
6 Severe Preoccupation with somatic complaints with much impairment in functioning 
OR somatic delusions without acting on them or disclosing to others. 
7 Extremely severe Preoccupation with somatic complaints with severe impairment in 
functioning OR somatic delusions that tend to be acted on or disclosed to others. 
"Have you been concerned about your physical health?" "Have you had any physical 
illness or seen a medical doctor lately? (What does your doctor say is wrong? How 
serious is it?)" 
"Has anything changed regarding your appearance?" 
"Has it interfered with your ability to perform your usual activities and/or work?" 
"Did you ever feel that parts of your body had changed or stopped working?" 
[If individual reports any somatic concerns/delusions, ask the following]: 
"How often are you concerned about [use individual's description]?" 
"Have you expressed any of these concerns to others?" 
2. Anxiety
Reported apprehension, tension, fear, panic or worry. Rate only the individual's 
statements - not observed anxiety which is rated under Tension. 
2 Very mild Reports some discomfort due to worry OR infrequent worries that occur 
more than usual for most normal individuals. 
3 Mild Worried frequently but can readily turn attention to other things. 
4 Moderate Worried most of the time and cannot turn attention to other things easily but 
no impairment in functioning OR occasional anxiety with autonomic accompaniment but 
no impairment in functioning. 
5 Moderately Severe Frequent, but not daily, periods of anxiety with autonomic 
accompaniment OR some areas of functioning are disrupted by anxiety or worry. 
6 Severe Anxiety with autonomic accompaniment daily but not persisting throughout the 
day OR many areas of functioning are disrupted by anxiety or constant worry. 
7 Extremely Severe Anxiety with autonomic accompaniment persisting throughout the 
day OR most areas of functioning are disrupted by anxiety or constant worry. 
"Have you been worried a lot during [mention time frame]? Have you been nervous or 
apprehensive? (What do you worry about?)" 
"Are you concerned about anything? How about finances or the future?" 
"When you are feeling nervous, do your palms sweat or does your heart beat fast (or 
shortness of breath, trembling, choking)?" 
[If individual reports anxiety or autonomic accompaniment, ask the following]: 
"How much of the time have you been [use individual's description]?" 
"Has it interfered with your ability to perform your usual activities/work?" 
3. Depression
Include sadness, unhappiness, anhedonia and preoccupation with depressing topics 
(can't attend to TV or conversations due to depression), hopeless, loss of self-esteem
(dissatisfied or disgusted with self or feelings of worthlessness). Do not include
vegetative symptoms, e.g., motor retardation, early waking or the amotivation that
accompanies the deficit syndrome. 
2 Very mild Occasionally feels sad, unhappy or depressed. 
3 Mild Frequently feels sad or unhappy but can readily turn attention to other things. 
4 Moderate Frequent periods of feeling very sad, unhappy, moderately depressed, but 
able to function with extra effort. 
5 Moderately Severe Frequent, but not daily, periods of deep depression OR some 
areas of functioning are disrupted by depression. 
6 Severe Deeply depressed daily but not persisting throughout the day OR many areas 
of functioning are disrupted by depression. 
7 Extremely Severe Deeply depressed daily OR most areas of functioning are disrupted
by depression. 
"How has your mood been recently? Have you felt depressed (sad, down, unhappy, as if 
you didn't care)?" 
"Are you able to switch your attention to more pleasant topics when you want to?" 
"Do you find that you have lost interest in or get less pleasure from things you used to 
enjoy, like family, friends, hobbies, watching TV, eating?" 
[If individual reports feelings of depression, ask the following]: 
"How long do these feelings last?" "Has it interfered with your ability to perform your 
usual activities?" 
4. Suicidality
Expressed desire, intent, or actions to harm or kill self. 
2 Very mild Occasional feelings of being tired of living. No overt suicidal thoughts. 
3 Mild Occasional suicidal thoughts without intent or specific plan OR he/she feels they 
would be better off dead. 
4 Moderate Suicidal thoughts frequent without intent or plan. 
5 Moderately Severe Many fantasies of suicide by various methods. May seriously 
consider making an attempt with specific time and plan OR impulsive suicide attempt 
using non-lethal method or in full view of potential saviours. 
6 Severe Clearly wants to kill self. Searches for appropriate means and time, OR
potentially serious suicide attempt with individual knowledge of possible rescue. 
7 Extremely Severe Specific suicidal plan and intent (e.g., "as soon as ________ I will 
do it by doing X"), OR suicide attempt characterised by plan individual thought was lethal 
or attempt in secluded environment. 
"Have you felt that life wasn't worth living? Have you thought about harming or killing 
yourself? Have you felt tired of living or as though you would be better off dead? Have 
you ever felt like ending it all?"
[If individual reports suicidal ideation, ask the following]: 
"How often have you thought about [use individual's description]?" 
"Did you (Do you) have a specific plan?" 
5. Guilt
Overconcern or remorse for past behaviour. Rate only individual's statements, do not 
infer guilt feelings from depression, anxiety, or neurotic defences. Note: if the individual
rates 6 or 7 due to delusions of guilt, then you must rate Unusual Thought Content at 
least 4 or above, depending on level of preoccupation and impairment. 
2 Very mild Concerned about having failed someone, or at something, but not
preoccupied. Can shift thoughts to other matters easily. 
3 Mild Concerned about having failed someone, or at something, with some
preoccupation. Tends to voice guilt to others. 
4 Moderate Disproportionate preoccupation with guilt, having done wrong, injured others 
by doing or failing to do something, but can readily turn attention to other things. 
5 Moderately Severe Preoccupation with guilt, having failed someone or at something, 
can turn attention to other things, but only with great effort. Not delusional. 
6 Severe Delusional guilt OR unreasonable self-reproach very out of proportion to 
circumstances. Moderate preoccupation present. 
7 Extremely Severe Delusional guilt OR unreasonable self-reproach grossly out of 
proportion to circumstances. Individual is very preoccupied with guilt and is likely to 
disclose to others or act on delusions. 
"Is there anything you feel guilty about? Have you been thinking about past problems?" 
"Do you tend to blame yourself for things that have happened?" 
"Have you done anything you're still ashamed of?" 
[If individual reports guilt/remorse/delusions, ask the following]: 
"How often have you been thinking about [use individual's description]?" 
"Have you disclosed your feelings of guilt to others?"
6. Hostility
Animosity, contempt, belligerence, threats, arguments, tantrums, property destruction, 
fights, and any other expression of hostile attitudes or actions. Do not infer hostility from 
neurotic defences, anxiety or somatic complaints. Do not include incidents of appropriate 
anger or obvious self-defence.
2 Very mild Irritable or grumpy, but not overtly expressed. 
3 Mild Argumentative or sarcastic. 
4 Moderate Overtly angry on several occasions OR yelled at others excessively. 
5 Moderately Severe Has threatened, slammed about or thrown things. 
6 Severe Has assaulted others but with no harm likely, e.g., slapped or pushed, OR 
destroyed property, e.g., knocked over furniture, broken windows. 
7 Extremely Severe Has attacked others with definite possibility of harming them or with 
actual harm, e.g., assault with hammer or weapon. 
"How have you been getting along with people (family, co-workers, etc.)?" 
"Have you been irritable or grumpy lately? (How do you show it? Do you keep it to 
yourself?"
"Were you ever so irritable that you would shout at people or start fights or arguments? 
(Have you found yourself yelling at people you didn't know?)" 
"Have you hit anyone recently?" 
7. Elevated Mood
A pervasive, sustained and exaggerated feeling of well-being, cheerfulness, euphoria 
(implying a pathological mood), optimism that is out of proportion to the circumstances. 
Do not infer elation from increased activity or from grandiose statements alone. 
2 Very mild Seems to be very happy, cheerful without much reason. 
3 Mild Some unaccountable feelings of well-being that persist. 
4 Moderate Reports excessive or unrealistic feelings of well-being, cheerfulness,
confidence or optimism inappropriate to circumstances, some of the time. May frequently 
joke, smile, be giddy, or overly enthusiastic OR few instances of marked elevated mood 
with euphoria. 
5 Moderately Severe Reports excessive or unrealistic feelings of well-being, confidence 
or optimism inappropriate to circumstances, much of the time. May describe feeling `on 
top of the world', `like everything is falling into place', or `better than ever before', OR 
several instances of marked elevated mood with euphoria. 
6 Severe Reports many instances of marked elevated mood with euphoria OR mood 
definitely elevated almost constantly throughout interview and inappropriate to content. 
7 Extremely Severe Individual reports being elated or appears almost intoxicated, 
laughing, joking, giggling, constantly euphoric, feeling invulnerable, all inappropriate to 
immediate circumstances. 
"Have you felt so good or high that other people thought that you were not your normal 
self?" "Have you been feeling cheerful and `on top of the world' without any reason?"
[If individual reports elevated mood/euphoria, ask the following]: 
"Did it seem like more than just feeling good?" 
"How long did that last?" 
8. Grandiosity
Exaggerated self-opinion, self-enhancing conviction of special abilities or powers or
identity as someone rich or famous. Rate only individual's statements about himself, not 
his/her demeanour. Note: if the individual rates 6 or 7 due to grandiose delusions, you 
must rate Unusual Thought Content at least 4 or above. 
2 Very mild Feels great and denies obvious problems, but not unrealistic. 
3 Mild Exaggerated self-opinion beyond abilities and training.
4 Moderate Inappropriate boastfulness, e.g., claims to be brilliant, insightful or gifted 
beyond realistic proportions, but rarely self-discloses or acts on these inflated self-
concepts. Does not claim that grandiose accomplishments have actually occurred. 
5 Moderately Severe Same as 4 but often self-discloses and acts on these grandiose 
ideas. May have doubts about the reality of the grandiose ideas. Not delusional. 
6 Severe Delusional - claims to have special powers like ESP, to have millions of
dollars, invented new machines, worked at jobs when it is known that he/she was never 
employed in these capacities, be Jesus Christ, or the Prime Minister. Individual may not 
be very preoccupied. 
7 Extremely Severe Delusional - same as 6 but individual seems very preoccupied and 
tends to disclose or act on grandiose delusions. 
"Is there anything special about you? Do you have any special abilities or powers? Have 
you thought that you might be somebody rich or famous?"
[If the individual reports any grandiose ideas/delusions, ask the following]: 
"How often have you been thinking about [use individuals description]? Have you told 
anyone about what you have been thinking? Have you acted on any of these ideas?"
9. Suspiciousness
Expressed or apparent belief that other persons have acted maliciously or with
discriminatory intent. Include persecution by supernatural or other non-human agencies 
(e.g., the devil). Note: ratings of 3 or above should also be rated under Unusual Thought 
Content.
2 Very mild Seems on guard. Reluctant to respond to some `personal' questions.
Reports being overly self-conscious in public. 
3 Mild Describes incidents in which others have harmed or wanted to harm him/her that 
sound plausible. Individual feels as if others are watching, laughing or criticising him/her 
in public, but this occurs only occasionally or rarely. Little or no preoccupation. 
4 Moderate Says other persons are talking about him/her maliciously, have negative 
intentions or may harm him/her. Beyond the likelihood of plausibility, but not delusional. 
Incidents of suspected persecution occur occasionally (less than once per week) with 
some preoccupation. 
5 Moderately Severe Same as 4, but incidents occur frequently, such as more than 
once per week. Individual is moderately preoccupied with ideas of persecution OR
individual reports persecutory delusions expressed with much doubt (e.g., partial
delusion).
6 Severe Delusional - speaks of Mafia plots, the FBI or others poisoning his/her food, 
persecution by supernatural forces. 
7 Extremely Severe Same as 6, but the beliefs are bizarre or more preoccupying. 
Individual tends to disclose or act on persecutory delusions. 
"Do you ever feel uncomfortable in public? Does it seem as though others are watching 
you? Are you concerned about anyone's intentions toward you? Is anyone going out of 
their way to give you a hard time, or trying to hurt you? Do you feel in any danger?"
[If individual reports any persecutory ideas/delusions, ask the following]: 
"How often have you been concerned that [use individual's description]? Have you told 
anyone about these experiences?" 
10. Hallucinations
Reports of perceptual experiences in the absence of relevant external stimuli. When 
rating degree to which functioning is disrupted by hallucinations, include preoccupation 
with the content and experience of the hallucinations, as well as functioning disrupted by 
acting out on the hallucinatory content (e.g., engaging in deviant behaviour due to 
command hallucinations). Include thoughts aloud (`gedenkenlautwerden') or
pseudohallucinations (e.g., hears a voice inside head) if a voice quality is present. 
2 Very mild While resting or going to sleep, sees visions, smells odours or hears voices, 
sounds, or whispers in the absence of external stimulation, but no impairment in
functioning.
3 Mild While in a clear state of consciousness, hears a voice calling the individual's 
name, experiences non-verbal auditory hallucinations (e.g., sounds or whispers),
formless visual hallucinations or has sensory experiences in the presence of a modality-
relevant stimulus (e.g., visual illusions) infrequently (e.g., 1-2 times per week) and with 
no functional impairment. 
4 Moderate Occasional verbal, visual, gustatory, olfactory or tactile hallucinations with 
no functional impairment OR non-verbal auditory hallucinations/visual illusions more 
than infrequently or with impairment. 
5 Moderately Severe Experiences daily hallucinations OR some areas of functioning 
are disrupted by hallucinations. 
6 Severe Experiences verbal or visual hallucinations several times a day OR many 
areas of functioning are disrupted by these hallucinations. 
7 Extremely Severe Persistent verbal or visual hallucinations throughout the day OR 
most areas of functioning are disrupted by these hallucinations.
"Do you ever seem to hear your name being called?" 
"Have you heard any sounds or people talking to you or about you when there has been 
nobody around? 
[If hears voices]: 
"What does the voice/voices say? Did it have a voice quality?" 
"Do you ever have visions or see things that others do not see? What about smell 
odours that others do not smell?" 
[If the individual reports hallucinations, ask the following]: 
"Have these experiences interfered with your ability to perform your usual
activities/work? How do you explain them? How often do they occur?" 
11. Unusual thought content
Unusual, odd, strange, or bizarre thought content. Rate the degree of unusualness, not 
the degree of disorganisation of speech. Delusions are patently absurd, clearly false or 
bizarre ideas that are expressed with full conviction. Consider the individual to have full 
conviction if he/she has acted as though the delusional belief was true. Ideas of
reference/persecution can be differentiated from delusions in that ideas are expressed 
with much doubt and contain more elements of reality. Include thought insertion,
withdrawal and broadcast. Include grandiose, somatic and persecutory delusions even if 
rated elsewhere. Note: if Somatic Concern, Guilt, Suspiciousness or Grandiosity are 
rated 6 or 7 due to delusions, then Unusual Thought Content must be rated 4 or above. 
2 Very mild Ideas of reference (people may stare or may laugh at him), ideas of
persecution (people may mistreat him). Unusual beliefs in psychic powers, spirits, UFOs, 
or unrealistic beliefs in one's own abilities. Not strongly held. Some doubt. 
3 Mild Same as 2, but degree of reality distortion is more severe as indicated by highly 
unusual ideas or greater conviction. Content may be typical of delusions (even bizarre), 
but without full conviction. The delusion does not seem to have fully formed, but is 
considered as one possible explanation for an unusual experience. 
4 Moderate Delusion present but no preoccupation or functional impairment. May be an 
encapsulated delusion or a firmly endorsed absurd belief about past delusional
circumstances.
5 Moderately Severe Full delusion(s) present with some preoccupation OR some areas 
of functioning disrupted by delusional thinking. 
6 Severe Full delusion(s) present with much preoccupation OR many areas of
functioning are disrupted by delusional thinking. 
7 Extremely Severe Full delusion(s) present with almost total preoccupation OR most 
areas of functioning disrupted by delusional thinking. 
"Have you been receiving any special messages from people or from the way things are 
arranged around you? Have you seen any references to yourself on TV or in the 
newspapers?"
"Can anyone read your mind?" 
"Do you have a special relationship with God?" 
"Is anything like electricity, X-rays, or radio waves affecting you?" 
"Are thoughts put into your head that are not your own?" 
"Have you felt that you were under the control of another person or force?" 
[If individual reports any odd ideas/delusions, ask the following]: 
"How often do you think about [use individual's description]?" 
"Have you told anyone about these experiences? How do you explain the things that 
have been happening [specify]?" 
Rate items 12-13 on the basis of individual's self-report and observed behaviour.
12. Bizarre behaviour
Reports of behaviours which are odd, unusual, or psychotically criminal. Not limited to 
interview period. Include inappropriate sexual behaviour and inappropriate affect. 
2 Very mild Slightly odd or eccentric public behaviour, e.g., occasionally giggles to self, 
fails to make appropriate eye contact, that does not seem to attract the attention of 
others OR unusual behaviour conducted in private, e.g., innocuous rituals, that would 
not attract the attention of others. 
3 Mild Noticeably peculiar public behaviour, e.g., inappropriately loud talking, makes 
inappropriate eye contact, OR private behaviour that occasionally, but not always,
attracts the attention of others, e.g., hoards food, conducts unusual rituals, wears gloves 
indoors.
4 Moderate Clearly bizarre behaviour that attracts or would attract (if done privately) the 
attention or concern of others, but with no corrective intervention necessary. Behaviour 
occurs occasionally, e.g., fixated staring into space for several minutes, talks back to 
voices once, inappropriate giggling/laughter on 1-2 occasions, talking loudly to self. 
5 Moderately Severe Clearly bizarre behaviour that attracts or would attract (if done 
privately) the attention of others or the authorities, e.g., fixated staring in a socially 
disruptive way, frequent inappropriate giggling/laughter, occasionally responds to voices, 
or eats non-foods.
6 Severe Bizarre behaviour that attracts attention of others and intervention by
authorities, e.g., directing traffic, public nudity, staring into space for long periods,
carrying on a conversation with hallucinations, frequent inappropriate giggling/laughter. 
7 Extremely Severe Serious crimes committed in a bizarre way that attract the attention 
of others and the control of authorities, e.g., sets fires and stares at flames OR almost 
constant bizarre behaviour, e.g., inappropriate giggling/laughter, responds only to
hallucinations and cannot be engaged in interaction. 
"Have you done anything that has attracted the attention of others?" 
"Have you done anything that could have gotten you into trouble with the police?" 
"Have you done anything that seemed unusual or disturbing to others?" 
13. Self-neglect
Hygiene, appearance, or eating behaviour below usual expectations, below socially 
acceptable standards or life threatening. 
2 Very mild Hygiene/appearance slightly below usual community standards, e.g., shirt 
out of pants, buttons unbuttoned, shoe laces untied, but no social or medical
consequences.
3 Mild Hygiene/appearance occasionally below usual community standards, e.g.,
irregular bathing, clothing is stained, hair uncombed, occasionally skips an important 
meal. No social or medical consequences. 
4 Moderate Hygiene/appearance is noticeably below usual community standards, e.g., 
fails to bathe or change clothes, clothing very soiled, hair unkempt, needs prompting, 
noticeable by others OR irregular eating and drinking with minimal medical concerns and 
consequences.
5 Moderately Severe Several areas of hygiene/appearance are below usual community 
standards OR poor grooming draws criticism by others and requires regular prompting. 
Eating or hydration are irregular and poor, causing some medical problems. 
6 Severe Many areas of hygiene/appearance are below usual community standards, 
does not always bathe or change clothes even if prompted. Poor grooming has caused 
social ostracism at school/residence/work, or required intervention. Eating erratic and 
poor, may require medical intervention. 
7 Extremely Severe Most areas of hygiene/appearance/nutrition are extremely poor and 
easily noticed as below usual community standards OR hygiene/appearance/nutrition 
require urgent and immediate medical intervention. 
"How has your grooming been lately? How often do you change your clothes? How often 
do you take showers? Has anyone (parents/staff) complained about your grooming or 
dress? Do you eat regular meals?"
14. Disorientation
Does not comprehend situations or communications, such as questions asked during the 
entire BPRS interview. Confusion regarding person, place, or time. Do not rate if
incorrect responses are due to delusions. 
2 Very mild Seems muddled or mildly confused 1-2 times during interview. Oriented to 
person, place and time. 
3 Mild Occasionally muddled or mildly confused 3-4 times during interview. Minor 
inaccuracies in person, place, or time, e.g., date off by more than 2 days, or gives wrong 
division of hospital or community centre. 
4 Moderate Frequently confused during interview. Minor inaccuracies in person, place,
or time are noted, as in 3 above. In addition, may have difficulty remembering general 
information, e.g., name of Prime Minister. 
5 Moderately Severe Markedly confused during interview, or to person, place, or time. 
Significant inaccuracies are noted, e.g., date off by more than one week, or cannot give 
correct name of hospital. Has difficulty remembering personal information, e.g., where 
he/she was born or recognising familiar people. 
6 Severe Disoriented as to person, place, or time, e.g., cannot give correct month and 
year. Disoriented in 2 out of 3 spheres. 
7 Extremely Severe Grossly disoriented as to person, place, or time, e.g., cannot give 
name or age. Disoriented in all three spheres. 
"May I ask you some standard questions we ask everybody?"
"How old are you? What is the date [allow 2 days]" 
"What is this place called? What year were you born? Who is the Prime Minister?" 
Rate items 15-24 on the basis of observed behaviour and speech.
15 Conceptual disorganisation
Degree to which speech is confused, disconnected, vague or disorganised. Rate
tangentiality, circumstantiality, sudden topic shifts, incoherence, derailment, blocking, 
neologisms, and other speech disorders. Do not rate content of speech. 
2 Very mild Peculiar use of words or rambling but speech is comprehensible. 
3 Mild Speech a bit hard to understand or make sense of due to tangentiality,
circumstantiality, or sudden topic shifts. 
4 Moderate Speech difficult to understand due to tangentiality, circumstantiality,
idiosyncratic speech, or topic shifts on many occasions OR 1-2 instances of incoherent 
phrases.
5 Moderately Severe Speech difficult to understand due to circumstantiality,
tangentiality, neologisms, blocking or topic shifts most of the time, OR 3-5 instances of 
incoherent phrases. 
6 Severe Speech is incomprehensible due to severe impairment most of the time. Many 
BPRS items cannot be rated by self-report alone. 
7 Extremely Severe Speech is incomprehensible throughout interview.
16. Blunted affect
Restricted range in emotional expressiveness of face, voice, and gestures. Marked 
indifference or flatness even when discussing distressing topics. In the case of euphoric 
or dysphoric individuals, rate Blunted Affect if a flat quality is also clearly present. 
2 Very mild Emotional range is slightly subdued or reserved but displays appropriate 
facial expressions and tone of voice that are within normal limits. 
3 Mild Emotional range overall is diminished, subdued or reserved, without many
spontaneous and appropriate emotional responses. Voice tone is slightly monotonous. 
4 Moderate Emotional range is noticeably diminished, individual doesn't show emotion, 
smile or react to distressing topics except infrequently. Voice tone is monotonous or 
there is noticeable decrease in spontaneous movements. Displays of emotion or
gestures are usually followed by a return to flattened affect. 
5 Moderately Severe Emotional range very diminished, individual doesn't show
emotion, smile, or react to distressing topics except minimally, few gestures, facial 
expression does not change very often. Voice tone is monotonous much of the time. 
6 Severe Very little emotional range or expression. Mechanical in speech and gestures 
most of the time. Unchanging facial expression. Voice tone is monotonous most of the 
time.
7 Extremely Severe Virtually no emotional range or expressiveness, stiff movements. 
Voice tone is monotonous all of the time. 
Use the following probes at end of interview to assess emotional responsivity: 
"Have you heard any good jokes lately? Would you like to hear a joke?"
17. Emotional withdrawal
Deficiency in individual's ability to relate emotionally during interview situation. Use your 
own feeling as to the presence of an `invisible barrier' between individual and
interviewer. Include withdrawal apparently due to psychotic processes. 
2 Very mild Lack of emotional involvement shown by occasional failure to make
reciprocal comments, appearing preoccupied, or smiling in a stilted manner, but
spontaneously engages the interviewer most of the time. 
3 Mild Lack of emotional involvement shown by noticeable failure to make reciprocal 
comments, appearing preoccupied, or lacking in warmth, but responds to interviewer 
when approached. 
4 Moderate Emotional contact not present much of the interview because individual 
does not elaborate responses, fails to make eye contact, doesn't seem to care if
interviewer is listening, or may be preoccupied with psychotic material. 
5 Moderately Severe Same as 4 but emotional contact not present most of the
interview.
6 Severe Actively avoids emotional participation. Frequently unresponsive or responds 
with yes/no answers (not solely due to persecutory delusions). Responds with only
minimal affect. 
7 Extremely Severe Consistently avoids emotional participation. Unresponsive or
responds with yes/no answers (not solely due to persecutory delusions). May leave 
during interview or just not respond at all.
18. Motor retardation
Reduction in energy level evidenced by slowed movements and speech, reduced body 
tone, decreased number of spontaneous body movements. Rate on the basis of
observed behaviour of the individual only. Do not rate on the basis of individual's 
subjective impression of his own energy level. Rate regardless of medication effects. 
2 Very mild Slightly slowed or reduced movements or speech compared to most people. 
3 Mild Noticeably slowed or reduced movements or speech compared to most people. 
4 Moderate Large reduction or slowness in movements or speech. 
5 Moderately Severe Seldom moves or speaks spontaneously OR very mechanical or 
stiff movements 
6 Severe Does not move or speak unless prodded or urged. 
7 Extremely Severe Frozen, catatonic.
19. Tension
Observable physical and motor manifestations of tension, `nervousness' and agitation. 
Self-reported experiences of tension should be rated under the item on anxiety. Do not 
rate if restlessness is solely akathisia, but do rate if akathisia is exacerbated by tension. 
2 Very mild More fidgety than most but within normal range. A few transient signs of 
tension, e.g., picking at fingernails, foot wagging, scratching scalp several times or finger 
tapping.
3 Mild Same as 2, but with more frequent or exaggerated signs of tension. 
4 Moderate Many and frequent signs of motor tension with one or more signs
sometimes occurring simultaneously, e.g., wagging one's foot while wringing hands 
together. There are times when no signs of tension are present. 
5 Moderately Severe Many and frequent signs of motor tension with one or more signs 
often occurring simultaneously. There are still rare times when no signs of tension are 
present.
6 Severe Same as 5, but signs of tension are continuous. 
7 Extremely Severe Multiple motor manifestations of tension are continuously present, 
e.g., continuous pacing and hand wringing.
20. Unco-operativeness
Resistance and lack of willingness to co-operate with the interview. The unco-
operativeness might result from suspiciousness. Rate only unco-operativeness in
relation to the interview, not behaviours involving peers and relatives.
2 Very mild Shows non-verbal signs of reluctance, but does not complain or argue. 
3 Mild Gripes or tries to avoid complying, but goes ahead without argument. 
4 Moderate Verbally resists but eventually complies after questions are rephrased or 
repeated.
5 Moderately Severe Same as 4, but some information necessary for accurate ratings 
is withheld. 
6 Severe Refuses to co-operate with interview, but remains in interview situation. 
7 Extremely Severe Same as 6, with active efforts to escape the interview
21. Excitement
Heightened emotional tone or increased emotional reactivity to interviewer or topics
being discussed, as evidenced by increased intensity of facial expressions, voice tone, 
expressive gestures or increase in speech quantity and speed.
2 Very mild Subtle and fleeting or questionable increase in emotional intensity. For 
example, at times seems keyed-up or overly alert. 
3 Mild Subtle but persistent increase in emotional intensity. For example, lively use of 
gestures and variation in voice tone. 
4 Moderate Definite but occasional increase in emotional intensity. For example, reacts 
to interviewer or topics that are discussed with noticeable emotional intensity. Some 
pressured speech. 
5 Moderately Severe Definite and persistent increase in emotional intensity. For 
example, reacts to many stimuli, whether relevant or not, with considerable emotional 
intensity. Frequent pressured speech. 
6 Severe Marked increase in emotional intensity. For example, reacts to most stimuli 
with inappropriate emotional intensity. Has difficulty settling down or staying on task. 
Often restless, impulsive, or speech is often pressured. 
7 Extremely Severe Marked and persistent increase in emotional intensity. Reacts to all 
stimuli with inappropriate intensity, impulsiveness. Cannot settle down or stay on task. 
Very restless and impulsive most of the time. Constant pressured speech. 
22. Distractibility
Degree to which observed sequences of speech and actions are interrupted by stimuli 
unrelated to the interview. Distractibility is rated when the individual shows a change in 
the focus of attention as characterised by a pause in speech or a marked shift in gaze. 
Individual's attention may be drawn to noise in adjoining room, books on a shelf, 
interviewer's clothing, etc. Do not rate circumstantiality, tangentiality or flight of ideas. 
Also, do not rate rumination with delusional material. Rate even if the distracting stimulus 
cannot be identified. 
2 Very mild Generally can focus on interviewer's questions with only 1 distraction or 
inappropriate shift of attention of brief duration. 
3 Mild Individual shifts focus of attention to matters unrelated to the interview 2-3 times. 
4 Moderate Often responsive to irrelevant stimuli in the room, e.g., averts gaze from the
interviewer.
5 Moderately Severe Same as above, but now distractibility clearly interferes with the 
flow of the interview. 
6 Severe Extremely difficult to conduct interview or pursue a topic due to preoccupation 
with irrelevant stimuli. 
7 Extremely Severe Impossible to conduct interview due to preoccupation with
irrelevant stimuli.
23. Motor hyperactivity
Increase in energy level evidenced in more frequent movement and/or rapid speech. Do 
not rate if restlessness is due to akathisia. 
2 Very mild Some restlessness, difficulty sitting still, lively facial expressions, or
somewhat talkative 
3 Mild Occasionally very restless, definite increase in motor activity, lively gestures, 1-3
brief instances of pressured speech. 
4 Moderate Very restless, fidgety, excessive facial expressions, or non-productive and 
repetitious motor movements. Much pressured speech, up to one-third of the interview. 
5 Moderately Severe Frequently restless, fidgety. Many instances of excessive non-
productive and repetitious motor movements. On the move most of the time. Frequent 
pressured speech, difficult to interrupt. Rises on 1-2 occasions to pace. 
6 Severe Excessive motor activity, restlessness, fidgety, loud tapping, noisy, etc.,
throughout most of the interview. Speech can only be interrupted with much effort. Rises 
on 3-4 occasions to pace. 
7 Extremely Severe Constant excessive motor activity throughout entire interview, e.g., 
constant pacing, constant pressured speech with no pauses, individual can only be 
interrupted briefly and only small amounts of relevant information can be obtained
24. Mannerisms and posturing
Unusual and bizarre behaviour, stylised movements or acts, or any postures which are 
clearly uncomfortable or inappropriate. Exclude obvious manifestations of medication
side effects. Do not include nervous mannerisms that are not odd or unusual. 
2 Very mild Eccentric or odd mannerisms or activity that ordinary persons would have 
difficulty explaining, e.g., grimacing, picking. Observed once for a brief period. 
3 Mild Same as 2, but occurring on two occasions of brief duration. 
4 Moderate Mannerisms or posturing, e.g., stylised movements or acts, rocking,
nodding, rubbing, or grimacing, observed on several occasions for brief periods or
infrequently but very odd. For example, uncomfortable posture maintained for 5 seconds 
more than twice. 
5 Moderately Severe Same as 4, but occurring often, or several examples of very odd 
mannerisms or posturing that are idiosyncratic to the individual. 
6 Severe Frequent stereotyped behaviour, assumes and maintains uncomfortable or 
inappropriate postures, intense rocking, smearing, strange rituals or foetal posturing. 
Individual can interact with people and the environment for brief periods despite these 
behaviours.
7 Extremely Severe Same as 6, but individual cannot interact with people or the 
environment due to these behaviours.
  
 
 
 
 
APPENDIX -VI 
 
 
 
 
 
 
 
 
 
1.  Gait:  The patient is examined as he walks into the 
examining room, his gait, the swing of his arms, his general 
posture, all form the basis for an overall score for this item.  
This is rated as follows: 
0      Normal 
1 Diminution in swing while the patient is walking 
2 Marked diminution in swing with obvious rigidity in the 
       arm 
3 Stiff gait with arms held rigidly before the abdomen 
4 Stooped shuffling gait with propulsion and retropulsion 
 
2. Arm Dropping:  The patient and the examiner both raise 
their arms to shoulder height and let them fall to their sides. 
In a normal subject, a stout slap is heard as the arms hit 
the sides.  In the patient with extreme Parkinson’s 
syndrome, the arms fall very slowly: 
0 Normal, free fall with loud slap and rebound 
1 Fall slowed slightly with less audible contact and little  
rebound 
2 Fall slowed, no rebound 
3 Marked slowing, no slap at all 
4 Arms fall as though against resistance; as though   
through glue 
 
3.     Shoulder Shaking:  The subject’s arms are bent at a right 
angle at the elbow and are taken one at a time by the  
examiner who grasps one hand and also clasps the other 
around the patient’s elbow.  The subject’s upper arm is 
pushed to and fro and the humerus is externally rotated. 
        The degree of resistance from normal to extreme rigidity is 
        scored as follows: 
0 Normal 
1 Slight stiffness and resistance 
2 Moderate stiffness and resistance   
3 Marked rigidity with difficulty in passive movement 
4 Extreme stiffness and rigidity with almost a frozen 
     shoulder 
 
 4.     Elbow Rigidity:  The elbow joints are separately bent at  
         right angles and passively extended and flexed, with the 
         subject’s biceps observed and simultaneously palpated. 
         The resistance to this procedure is rated.  (The presence of     
         cogwheel rigidity is noted separately.) 
0 Normal 
1 Slight stiffness and resistance 
2 Moderate stiffness and resistance 
3 Marked rigidity with difficulty in passive movement 
4 Extreme stiffness and rigidity with almost a frozen elbow 
 
 5.     Wrist Rigidity or Fixation of Position:  The wrist is held in  
         one hand and the fingers held by the examiner’s other hand, 
         with the wrist moved to extension, flexion and ulnar and radial 
         deviation:  
0     Normal 
1     Slight stiffness and resistance 
2     Moderate stiffness and resistance 
3     Marked rigidity with difficulty in passive movement 
4     Extreme stiffness and rigidity with almost frozen wrist   
 
 
 
 
 
 
 
 
6.     Leg Pendulousness:  The patient sits on a table with his 
        legs hanging down and swinging free.  The ankle is    
        grasped by the examiner and raised until the knee is 
        partially extended.  It is then allowed to fall.  The 
        resistance to falling and the lack of swinging form the 
        basis for the score on this item: 
        0     The legs swing freely 
        1     Slight diminution in the swing of the legs 
        2     Moderate resistance to swing 
        3     Marked resistance and damping of swing 
        4     Complete absence of swing 
 
7.     Head Dropping: The patient lies on a well-padded  
        examining table and his head is raised by the examiner’s 
        hand.  The hand is then withdrawn and the head allowed  
        to drop.  In the normal subject the head will fall upon the 
        table.  The movement is delayed in extrapyramidal 
        system disorder, and in extreme parkinsonism it is absent. 
        The neck muscles are rigid and the head does not reach 
        the examining table.  Scoring is as follows: 
0 The head falls completely with a good thump as it  
hits the table 
1 Slight slowing in fall, mainly noted by lack of slap as 
head meets the table 
2 Moderate slowing in the fall quite noticeable to the  
eye 
3 Head falls stiffly and slowly 
4 Head does not reach the examining table 
 
8.     Glabella Tap:  Subject is told to open eyes wide and not 
        to blink.  The glabella region is tapped at a steady, 
        rapid speed.  The number of times patient blinks in 
        succession is noted: 
0 0-5 blinks 
1 6-10 blinks 
2 11-15 blinks 
3 16-20 blinks 
4 21 and more blinks 
 
9.     Tremor:  Patient is observed walking into examining 
        room and is then reexamined for this item: 
0 Normal 
1 Mild finger tremor, obvious to sight and touch 
2 Tremor of hand or arm occurring spasmodically 
3 Persistent tremor of one or more limbs 
4 Whole body tremor 
 
10.  Salivation:  Patient is observed while talking and then 
        asked to open his mouth and elevate his tongue.  The 
        following ratings are given: 
0 Normal 
1 Excess salivation to the extent that pooling takes 
place if the mouth is open and the tongue raised 
2 When excess salivation is present and might 
occasionally result in difficulty speaking 
3 Speaking with difficulty because of excess salivation 
4 Frank drooling 
 
 
Patient Name:________________________________________________        Date: ____________________________ 
            
               SIMPSON-ANGUS EXTRAPYRAMIDAL SIDE EFFECTS SCALE 
 
The exam should be conducted in a room where the subject can walk a sufficient distance to allow him/her to get into a natural 
rhythm (e.g. 15 paces).  Each side of the body should be examined.  If one side shows more pronounced pathology than the 
other, this score should be noted and this taken.  Cogwheel rigidity may be palpated when the examination is carried out for 
items 3, 4, 5, and 6.  It is not rated separately and Is merely another way to detect rigidity.  It would indicate that a minimum 
score of 1 would be mandatory. 
Citation:  Simpson GM, Angus JWS:  A rating scale for extrapyramidal side effects.  Acta    
                Psychiatrica Scandinavica 212:11-19,1970 
 
  
 
 
 
APPENDIX -VII 
 
 
Name:________________________________________               Date:__________________ 
 
 
Barnes Akathisia Rating Scale (BARS) 
 
Instructions:  Patient should be observed while they are seated, and then standing while engaged in neutral 
conversation (for a minimum of two minutes in each position).  Symptoms observed in other situations, for 
example while engaged in activity on the ward, may also be rated.  Subsequently, the subjective phenomena 
should be elicited by direct questioning.   
 
Objective 
 
0 Normal, occasional fidgety movements of the limbs 
1 Presence of characteristic restless movements:  shuffling or tramping movements of the legs/feet, or 
swinging of one leg while sitting, and/or rocking from foot to foot or “walking on the spot” when standing, 
but movements present for less than half the time observed 
2 Observed phenomena, as described in (1) above, which are present for at least half the observation 
period 
3 Patient is constantly engaged in characteristic restless movements, and/or has the inability to remain 
seated or standing without walking or pacing, during the time observed 
 
Subjective 
 
Awareness of restlessness 
0 Absence of inner restlessness 
1 Non-specific sense of inner restlessness 
2 The patient is aware of an inability to keep the legs still, or a desire to move the legs, and/or complains 
of inner restlessness aggravated specifically by being required to stand still 
3 Awareness of intense compulsion to move most of the time and/or reports strong desire to walk or pace 
most of the time 
 
Distress related to restlessness 
0 No distress 
1 Mild 
2 Moderate 
3 Severe 
 
Global Clinical Assessment of Akathisia 
 
0 Absent.  No evidence of awareness of restlessness.  Observation of characteristic movements of  
 akathisia in the absence of a subjective report of inner restlessness or compulsive desire to move the 
 legs should be classified as pseudoakathisia 
1 Questionable.  Non-specific inner tension and fidgety movements 
2 Mild akathisia.  Awareness of restlessness in the legs and/or inner restlessness worse when required to 
 stand still.  Fidgety movements present, but characteristic restless movements of akathisia not  
 necessarily observed.  Condition causes little or no distress.   
3 Moderate akathisia.  Awareness of restlessness as described for mild akathisia above, combined with 
 characteristic restless movements such as rocking from foot to foot when standing.  Patient finds the  
 condition distressing 
4 Marked akathisia.  Subjective experience of restlessness includes a compulsive desire to walk or pace. 
 However, the patient is able to remain seated for at least five minutes.  The condition is obviously  
 distressing.   
5 Severe akathisia.  The patient reports a strong compulsion to pace up and down most of the time.   
 Unable to sit or lie down for more than a few minutes.  Constant restlessness which is associated with 
 intense distress and insomnia.   
 
 
 
  
 
Scoring the Barnes Akathisia Rating Scale (BARS) 
 
 
 The Barnes Akathisia Rating Scale is scored as follows: 
 
  Objective Akathisia, Subjective Awareness of Restlessness and Subjective Distress 
  Related to Restlessness are rated on a 4-point scale from 0 – 3 and are summed 
  yielding a total score ranging from 0 to 9.   
 
  The Global Clinical Assessment of Akathisia uses a 5-point scale ranging from 0 – 4.   
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Citation:  Barnes TR: A Rating Scale for Drug-Induced Akathisia.  British Journal of Psychiatry 154:672-676,     
               1989.   
  
 
 
 
APPENDIX -VIII 
 
Arizona Sexual Experiences Scale (ASEX) 
 Copyright 1997, Arizona Board of Regents, University of Arizona, All rights reserved. 
 
For each item, please indicate your OVERALL level during the PAST WEEK, including TODAY. 
 
1. How strong is your sex drive? 
1 
extremely 
strong 
2 
very strong 
3 
somewhat 
strong 
4 
somewhat 
weak 
5 
very weak 
6 
no sex drive 
 
 
2. How are you sexually aroused (turned on)? 
1 
extremely 
easily 
2 
very easily 
3 
somewhat 
easily 
4 
somewhat 
difficult 
5 
very 
difficult 
6 
never aroused 
 
 
FOR MALE ONLY 
3. Can you easily get and keep an erection? 
1 
extremely 
easily 
2 
very easily 
3 
somewhat 
easily 
4 
somewhat 
difficult 
5 
very 
difficult 
6 
never 
 
 
FOR FEMALE ONLY 
3.  How easily does your vagina become moist or wet during sex? 
1 
extremely 
easily 
2 
very easily 
3 
somewhat 
easily 
4 
somewhat 
difficult 
5 
very 
difficult 
6 
never 
 
 
If you have had any sexual activity in the past week, please also answer the following two 
questions. If not, leave questions 4, and 5 blank.  
                                                                                                        No Sexual activity in past week ............  
4. How easily can you reach an orgasm? 
1 
extremely 
easily 
2 
very easily 
3 
somewhat 
easily 
4 
somewhat 
difficult 
5 
very 
difficult 
6 
never reach 
orgasm 
 
 
5. Are your orgasms satisfying? 
1 
extremely 
satisfying 
2 
very 
satisfying 
3 
somewhat 
satisfying 
4 
somewhat 
unsatisfying 
5 
very 
unsatisfying 
 
6 
can't reach 
orgasm 
 
 
COMMENTS: 
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 Prolactin Related Adverse Event Questionnaire (PRAEQ) Form Version: 
04/10/07 jgh    
MPRCID#:  ___ ___ ___ ___ ___ ___ ___ Program ID:  ___ ___ ___ Date of Rating: ____/____/____ 
Subject Initials:  ___ ___  Rater ID:  ___ ___ Rater Initials:  ___ ___ 
Protocol ID#:    Protocol Name:     Date of Entry (DM):  ____/____/____ 
Protocol Phase:     Week/Visit#:    Recno:    
Notes: 
_______________________________________________________________________________________________ 
Was Form Completed? ____ (1=Yes, 2=No) If Not, Please Specify: ______________________________________ 
INSTRUCTIONS: Please rate the patient's experience, if any, with each of the following symptoms since their last study 
visit.  If they did not have the symptom, please check the box under the "Did Not Have" heading. 
MEN: Skip question ONE, then complete question TWO and THREE. 
WOMEN: Complete questions ONE and TWO, then STOP. 
 
How MUCH of the symptom did they have? How BOTHERED were they by the symptom? 
                                                      Did not Hardly A little  Medium Quite   Very Not at all                                       Extremely 
  have      any      bit     amount  a bit much   bothered                                         bothered 
1. Menstrual Changes  
  (Women Only)  0  1  2  3  4  5  1  2  3  4  5  6 
 a.  Longer than usual time between 
periods 
            
 b. Fewer days than usual of flow 
(bleeding) 
            
 c. Need smaller number pads or 
tampons than usual 
            
2.  Chest (breast) symptoms  
(Men and Women) 
            
 a. Increased breast size             
 b.  Unusual breast tenderness             
 c.  Visible fluid at one or both 
nipples 
            
 d.  Staining of underclothes or bed 
sheets 
            
 e.  Crusting at nipples             
3.  Penile function (Men Only)             
 a.  Fewer night time erections             
 b.  Difficulty achieving erection             
 c.  Fewer "wet dreams"             
 d.  Difficulty achieving ejaculation             
     
